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Kim, Yeji. Ph.D., Purdue University, December 2014. Modulating Cell Differentiation 
with Protein-Engineered Microenvironments. Major Professor: Julie C. Liu. 
Tissue damage caused by diseases and injuries requires regeneration to recover 
proper tissue function. Traditional treatments using autologous tissue have not yet met 
the need for tissue regeneration. Tissue engineering has emerged as an alternative 
strategy for tissue regeneration. It utilizes biomaterials that mimic native cellular 
microenvironments and provide environmental cues to induce specific cell responses, 
including differentiation. Biochemical and biophysical cues modulate cell behavior and 
direct construction of specific types of tissue. Thus, this work describes production and 
characterization of protein-engineered microenvironments that provide biochemical and 
biophysical cues to modulate stem cell differentiation. 
 We created modular proteins containing two domains, a resilin structural domain 
and bioactive domains. The resilin domain (RZ) includes ten repeats of a resilin-like 
sequence, which are derived from the African malaria mosquito and provide mechanical 
integrity. Depending on the targeted cell response, the bioactive domains include peptide 
sequences derived from growth factors or extracellular matrix proteins. Protein-
engineered microenvironments were created as adsorbed protein layers or crosslinked 
matrices. 
First, we produced RZ-BMP proteins containing a peptide derived from bone 
morphogenetic protein-2 (BMP-2 peptide) and examined the effect of this biochemical 
cue on osteogenic differentiation of human mesenchymal stem cells (hMSCs). Cells 
cultured on the RZ-BMP proteins had increased levels of osteogenic markers, such as 





Our results show that, within the context of our proteins, the BMP-2 peptide was active 
and accelerated osteogenic differentiation of hMSCs. We also examined whether there is 
a synergistic effect of the BMP-2 peptide and the RGD cell-binding sequence on 
osteogenic differentiation but found that there was no synergy within the context of our 
proteins. 
Next, we switched the biochemical cue in our microenvironments to achieve a 
different type of cell differentiation. Instead of the BMP-2 peptide, a peptide derived 
from vascular endothelial growth factor (QK peptide) was included in the RZ-QK protein 
to induce endothelial differentiation. We demonstrated that endothelial differentiation of 
hMSCs was achieved on the RZ-QK proteins in the absence of exogenous growth factors 
as the RZ-QK proteins promoted endothelial-specific markers and endothelial functions. 
In particular, cells on our proteins exhibited statistically equivalent network formation as 
positive control cells.  
Finally, we evaluated the effect of biophysical cues (i.e., matrix stiffness) on cell 
responses such as spreading and endothelial differentiation. We used proteins containing 
the RGD cell-binding sequence to promote cell adhesion. The proteins were crosslinked 
with transglutaminase (TGase) to create RZ-TGase matrices with varying stiffness, and 
the stiffness of our matrices was similar to that of subendothelial environments. The 
matrix stiffness modulated spreading and endothelial differentiation of hMSCs as the 
stiffest matrices promoted greater cell spreading and higher endothelial function 
compared to the softest matrices. Of particular note, our RZ-TGase matrices promoted 
statistically equivalent endothelial function as hard surfaces, which are routinely used for 
conventional cell differentiation but are much stiffer than the subendothelial matrix. Thus, 
our tunable matrix system is a promising tool to provide more native subendothelial 





CHAPTER 1. INTRODUCTION 
1.1 Overview of Tissue Engineering 
Tissue damage caused by diseases and injuries requires regeneration to recover 
proper tissue function. Traditionally, severe defects in tissues and organs have been 
treated by transplantation of tissue obtained from human or animals. However, 
autologous tissues from the patient‘s body have significant disadvantages such as limited 
availability of donor tissue, chronic donor site pain, and additional surgery for harvesting 
donor tissue. In contrast, the use of allogeneic (i.e., tissues from the same species) or 
xenographic (i.e., tissue from animals) tissues for regeneration is limited by possible 
disease transmission from donor to recipient and by the immune response after 
implantation. Due to these limitations, traditional treatments have not yet met the need 
for tissue regeneration. In 2007, the number of people in the waiting list for an organ was 
100,000, while 6,300 patients who had been on the list died [1]. 
Tissue engineering has emerged as an alternative strategy for tissue regeneration as 
it overcomes drawbacks associated with traditional regeneration methods. Engineered 
tissues can be produced with autologous cells to reduce immunogenicity issues and 
scaled up to satisfy increasing demands. Tissue engineering utilizes biomaterials that can 
be manufactured by applying concepts in the field of engineering, material science, and 
cell biology. The biomaterials are intended to mimic native cellular microenvironments 
and provide environmental cues to induce specific cell responses such as proliferation, 
migration, differentiation, and eventually tissue regeneration. Among environmental cues, 
biophysical and biochemical cues have been used and investigated in many studies to 
modulate cell behavior. For example, matrix stiffness and growth factors have been 






1.2 Components of Engineered Tissue 
To mimic architecture found in native bone and vascular tissues, engineered 
tissues consist of cells, scaffolds, and environmental cues, which would work in concert 
to accelerate tissue regeneration upon implantation.  
 
Cells: 
Cells are incorporated into engineered scaffolds to produce and maintain 
extracellular matrix (ECM). Autologous cells would be the gold standard as they already 
exhibit desired functional characteristics and avoid immunogenicity issues. However, 
generally it is difficult to obtain autologous cells in large quantities.   
Mesenchymal stem cells (MSCs) have been widely used for bone and vascular 
tissue engineering. They can be easily isolated from bone marrow and expanded in vitro. 
The Friedenstein group was the first to provide evidence of the osteogenic (bone-forming) 
potential of MSCs [2], and Bruder et al. showed the use of MSCs in repairing bone 
defects in large animals [3]. However, in vivo bone formation of MSCs remains quite 
unpredictable due to a relatively low commitment towards the osteogenic lineage [4]. 
Therefore, the use of bioactive cues such as dexamethasone (100 nM) [5] or growth 
factors (e.g., bone morphogenetic proteins (BMPs)) has been proposed to overcome the 
problem.   
MSCs also have the potential to differentiate towards other lineages such as 
adipogenic, neurogenic, and endothelial lineages. In particular, in vitro endothelial 
differentiation of MSCs was demonstrated by Oswald et al [6]. When cultured with 
biochemical cues (i.e., vascular endothelial growth factor (VEGF)), MSCs showed a 
substantial expression of endothelial-specific markers such as VEGF receptors (KDR and 
VEGFR-1) and von Willebrand factor (vWF). In addition, endothelial differentiation of 
MSCs has been achieved by several different culture conditions such as serum 









Scaffolds act as a temporary matrix while new tissue is regenerated. They provide 
mechanical support; a suitable environment that allows cells to attach, migrate, 
proliferate, and differentiate for new tissue formation; and reservoirs for nutrients, 
cytokines, and growth factors.  
Various materials have been developed as bone scaffolds, including bioactive 
inorganic materials, polymers, and composite materials. Bioactive inorganic materials 
such as hydroxyapatite (HA) and tricalciumphosphate (TCP) are similar in composition 
to that of the mineral phase in native bone, but they are too brittle to be used in load-
bearing sites [9]. Synthetic polymers such as polylactic acid (PLA), polyglycolic acid 
(PGA), copolymers of PLA and PGA (PLGA), and polycaprolactone (PCL) can be 
processed into different sizes and shapes and modified to change their physical and 
chemical properties [10]. Nevertheless, their applications are limited by inflammatory 
responses to degradation products. In addition, in order to mimic the composite nature of 
native bone, polymer/inorganic composite materials such as PLGA/HA have been studied. 
However, the mechanical integrity of current composites is still lower than that of cortical 
or cancellous bone [11]. 
Vascular scaffolds have been constructed using different materials. Synthetic grafts 
such as poly(ethylene terephthalate) (PET) and expanded poly(tetrafluoroethylene) 
(ePTFE) have been clinically employed [12]. Because PET and ePTFE cannot be 
resorbed, the use of PLGA and PCL scaffolds has been proposed for vessel 
reconstruction because of their biodegradability [13]. In addition, collagen- and fibrin-
based vessel scaffolds can promote cell attachment and cellular signaling, but they are not 
mechanically robust enough to withstand blood pressure [13]. In contrast, decellularized 
scaffolds such as small intestinal submucosa (SIS) exhibit better compliance compared to 
PET and ePTFE [14], but their application for vessel regeneration is hampered by 
potential immunogenicity issues. 
Alternatively, genetically engineered protein-based biomaterials have been 
considered as potential scaffolds for bone and vascular tissue engineering applications. 





Because genetic engineering allows incorporation of multiple peptide motifs into one 
material, production is relatively simple and material properties can be easily tuned. Also, 
recombinant protein reduces concerns about immunogenicity and disease transmission 
resulting from the use of natural protein. 
As an example of protein-based biomaterials, recombinant collagen has been shown 
to direct mineralization by formation of HA crystals [15], and these mineralized 
collagens promoted regeneration in rabbit bone defects [16]. Spider silk-silica fusion 
protein scaffolds promoted growth and osteogenic differentiation of human MSCs [17]. 
Several attempts have also been made to construct protein-based scaffolds for vascular 
tissue engineering. Recombinant tropoelastin and elastin-like polypeptides scaffolds 
supported proliferation of smooth muscle cells [18] and human umbilical vein endothelial 
cells [19], respectively. 
 
Environmental Cues: 
  In native tissue, cells are surrounded by microenvironmental cues that affect cell 
behavior. The cues are classified into four different types, biochemical cues (e.g., growth 
factors and ligands), biophysical cues (e.g., stiffness, topography, and shear stress or 
strain), extracellular matrix proteins (i.e., collagen, laminin, proteoglycans, and 
fibronectin), and cell-to-cell interaction (i.e., Notch signaling and cadherins) [20]. Among 
the cues, growth factors and stiffness have been widely employed into engineered tissues 
to mimic native microenvironments and induce desired cell responses.  
Growth factors and ECM ligands are molecules that influence specific cellular 
function by binding to receptors present in the cell membrane. BMPs are known to 
induce osteogenic differentiation of stem cells [21]. VEGF is utilized to promote 
endothelial differentiation of MSCs [6] and modulate arterial or venous specification of 
human MSCs [22]. The small peptide sequences derived from BMP-2 (i.e., BMP-2 
peptide) and VEGF (i.e., QK peptide) were reported to mimic the function of full-length 
BMP-2 and VEGF, respectively [23, 24]. The peptide arginine-glycine-aspartic acid 





These biochemical cues have been incorporated into scaffolds to localize cue 
concentration and enable prolonged signaling. Several studies demonstrated that the 
BMP-2 peptide incorporated into scaffolds promoted osteogenic differentiation of MSCs 
and has a synergistic effect with RGD on osteogenic differentiation [25-28]. The QK-
incorporated scaffolds promoted proliferation and function of endothelial cells [29-33]. 
The stiffness of the matrix or scaffold where cells are grown has been shown to 
modulate cell behavior. Previous reports showed that stem cell fate can be determined by 
stiffness of two-dimensional (2D) and three-dimensional (3D) microenvironments. For 
example, osteogenic differentiation of MSCs occurred on 2D substrate with a stiffness of 
25-40 kPa [34] and in a 3D matrix with a 11-30 kPa [35]. In addition, mature endothelial 
cells on or in gels of varying stiffnesses exhibited different migration behavior [36], 
network formation [37], and sprouting and outgrowth [38].  
Furthermore, it was suggested that the interplay of biochemical cues and material 
stiffness direct cell differentiation. One study reported that osteogenic differentiation with 
full-length BMP-2 was enhanced when matrix stiffness increased from 1 to 32 kPa. 
Another study demonstrated that the BMP-2 peptide on a stiff matrix of 45-49 kPa 
enhanced osteogenic differentiation of human MSCs, whereas the peptide on a soft 
matrix of 1-3 kPa had no effect on osteogenic differentiation [39]. For endothelial 
differentiation, a combination of matrix stiffness and VEGF had a synergistic effect on 
MSC differentiation, as a matrix of 2 kPa and VEGF improved cell differentiation 
compared to the matrix or VEGF alone [40]. 
1.3 Modular Protein Design 
For this thesis, we designed modular proteins that provide human MSCs 
microenvironmental cues to promote specific responses such as cell adhesion and 
differentiation. Using modular proteins, engineered microenvironments were created as 






Figure 1.3.1. Resilin-based modular proteins used in this thesis. Proteins consist of two 
different domains. The structural domain contains ten repeats of a resilin-like sequence 
(red) and potential crosslinking sites (black). The bioactive domain (blue) contains the 
BMP-2 peptide (for the RZ-BMP protein in Chapter 2), the QK peptide (for the RZ-QK 
protein in Chapter 3), or the RGD sequence (for the RZ-RGD protein in Chapter 4), 
depending on the intended cellular responses. A cleavable tag (purple) is included for 
protein identification and purification. The RZ-scBMP, RZ-scQK, and RZ-scRGD 
proteins serve as sequence-scrambled negative control proteins. 
The proteins consist of two domains, structural and bioactive domains, as shown in 
Figure 1.3.1. The resilin structural domain, referred to as RZ, includes ten repeats of a 
resilin-like sequence (AQTPSSQYGAP) derived from the African malaria mosquito 
Anopheles gambiae and provides mechanical integrity. The sequence in the resilin 
domain has amino acids that offer crosslinking sites. First, a lysine (K) residue is 
included next to a glutamine (Q) residue once every two resilin repeats to provide a 
crosslinking site. The lysine residues can be crosslinked by the amine reactive crosslinker 
tris(hydroxymethyl)phosphine (THP). It was reported that the THP-mediated crosslinking 
reaction releases only water [41]. Second, the glutamine (Q) and lysine (K) residues in 
the resilin domain can be utilized for transglutaminase-mediated crosslinking sites as the 
enzyme forms covalent bonds between Q and K [42]. Third, the tyrosine (Y) residue in 
the original resilin sequence was replaced by phenylalanine (F) to serve as a potential 
crosslinking site. A bacterial host that harbors a mutated phenylalanyl tRNA synthetase 
can incorporate the non-natural amino acid para-azido phenylalanine into phenylalanine 
sites [43]. UltraViolet (UV) light can be used to crosslink p-azido phenylalanine residues.  
Each resilin-based modular protein contains a different biochemical cue such as 1) 
the BMP-2 peptide for the RZ-BMP protein (Chapter 2), 2) the QK peptide for the RZ-

























(Chapter 4). Briefly, the BMP-2 and QK peptides are intended to promote osteogenic and 
endothelial differentiation as they mimic the function of full-length BMP-2 and VEGF, 
respectively [24, 44]. The RGD sequence is incorporated to enhance cell adhesion. In 
order for each protein to have approximately the same length and molecular weight, five 
glycine residues (G) are placed on either side of the QK and RGD sequences. Each 
protein includes tags on the N-terminus – a T7 tag for protein identification, a 
heptahistidine (His) tag for protein purification, and an enterokinase cleavage site for 
removal of the tags. 
 
Resilin: 
Resilin is one of the elastomeric proteins present in the insect cuticle. It exhibits 
high resilience [45] and a very high fatigue lifetime [46]. It plays a significant role in the 
jumping mechanism of fleas [47], the flight system of locusts [48], leg movement in 
arachnids [49], and sound production in cicadas [50]. Similar to other elastic proteins, 
resilin has repetitive sequences. The soluble precursor of resilin (pro-resilin) contains 
tyrosine residues that can be crosslinked to generate di- and tri-tyrosines linkages, 
thereby forming a three-dimensional network [51].  
Resilin-based recombinant proteins have been produced to potentially serve as 
scaffolds for tissue engineering applications. In one study, a putative resilin gene 
(CG15920) within Drosophila melanogaster (fruitfly) was identified [52], and 
recombinant protein containing the first exon of this gene (i.e., rec1-resilin) was cloned 
and expressed as a soluble form in Escherichia coli [53]. The resilin sequence from D. 
melanogaster has been used and studied for vocal fold regeneration [54] and 
cardiovascular tissue engineering [55]. In addition, recombinant resilin protein, which 
includes resilin sequences from A. gambiae, displayed similar mechanical properties to 
rec1-resilin [56] and was examined for cartilage tissue engineering [57].  
Resilin-based proteins have been functionalized for versatile cellular functions. 
The Kiick group introduced three types of bioactive peptides to resilin-based proteins; the 
RGD cell-binding sequence for cell adhesion, a matrix metalloproteinase (MMP) 





sequestration and controlled release of growth factors such as VEGF and basic fibroblast 
growth factor (FGF) [54, 55, 58]. They demonstrated that proteins supported cell 
attachment and adhesion by RGD and were enzymatically degradable due to the MMP-
sensitive sequence [54]. Our group included the RGD sequence in resilin-based proteins, 
and the proteins promoted cell adhesion [57]. Therefore, functionalization of resilin-
based proteins with bioactive peptide motifs can broaden their use for tissue engineering 
applications. 
1.4 Thesis Outline and Contributions 
The goal of this thesis was to create protein-engineered microenvironments to 
promote stem cell responses such as adhesion and differentiation. The biochemical and 
biophysical cues serve as microenvironmental cues, and the effect of these cues on cell 
responses were explored. We show that stem cell differentiation can be modulated by 
switching biochemical cues (i.e., bioactive peptide) in resilin-based microenvironments in 
Chapter 2 and 3 and by varying biophysical cues (i.e., matrix stiffness) in Chapter 4. For 
this document, I produced proteins, planned and performed all experiments, and wrote all 
of the chapters unless otherwise stated. 
Chapter 2 describes the effect of a biochemical cue (i.e., BMP-2 peptide) on 
osteogenic differentiation of human MSCs. The BMP-2 peptide was incorporated into 
genetically-engineered resilin protein, and human MSCs were grown on protein surfaces 
in osteogenic differentiation medium. Cell differentiation was examined by 
characterizing osteogenic markers such as calcium deposition, enzyme activity, and gene 
expression. Our data showed that the protein containing the BMP-2 peptide was 
cytocompatible and supported cellular metabolic activity. In addition, the BMP-2 peptide 
in our protein surface was active and accelerated osteogenic differentiation of human 
MSCs compared to the control surface. Dr. Julie N. Renner designed and cloned the 
DNA encoding resilin proteins containing the BMP-2 peptide. 
Chapter 3 explores the effect of another biochemical cue (i.e., the QK peptide) on 
endothelial differentiation of human MSCs. The QK peptide was included in the resilin-





differentiation was characterized by evaluating endothelial marker expression and 
endothelial functions. Our data demonstrate that endothelial differentiation of human 
MSCs was achieved in the absence of exogenous growth factors. Our protein-based 
microenvironments supported cell viability and metabolic activity and promoted 
endothelial-specific markers and endothelial functions. In particular, cells on our protein 
exhibited statistically equivalent network formation to positive control cells.  
Chapter 4 describes the effect of matrix stiffness on cell response. The RGD cell-
binding sequence was incorporated in the resilin-based protein. The resilin-based protein 
matrices were produced by transglutaminase-mediated crosslinking. We demonstrated 
that matrix stiffness can be tuned by varying total protein concentration. Our data 
demonstrated that the matrix was cytocompatible and supported cell proliferation. In 
addition, cell spreading and differentiation were modulated by matrix stiffness as the 
stiffest matrices promoted greater cell spreading and higher endothelial differentiation 
compared to the softest matrices. Emily E. Gill performed experiments to measure 
swelling ratio and water content of the crosslinked resilin matrices.  
Chapter 5 describes the summary and major conclusions from this research and 







CHAPTER 2. INCORPORATING THE BMP-2 PEPTIDE IN GENETICALLY-
ENGINEERED BIOMATERIALS ACCELERATES OSTEOGENIC 
DIFFERENTIATION 
This chapter consists of a manuscript by Kim Y, Renner JN, and Liu JC, published in 
Biomaterials Science, Volume 2, Issue 8, 2014 - Reproduced by permission of The Royal 
Society of Chemistry. 
2.1 Abstract 
Protein-based biomaterials have emerged as powerful tools for tissue engineering 
applications. Recombinant DNA techniques can be used to precisely tune material 
properties at the molecular level, and multiple peptide modules can be incorporated into a 
single material. Here, we genetically engineered biomaterials that incorporate a peptide 
derived from bone morphogenetic protein-2 (BMP-2) and investigated whether the BMP-
2 peptide, within the context of these materials, can promote stem cells to produce bone 
matrix and synergize with a cell-binding sequence (RGD). Our study is the first to 
demonstrate that when the BMP-2 peptide is incorporated within the backbone of protein-
based biomaterials, it is active and accelerates osteogenic differentiation of mesenchymal 
stem cells. In particular, cells seeded on proteins containing the BMP-2 peptide had 
increased levels of alkaline phosphatase (AP) activity, calcium deposition, and expression 
of bone-related genes. However, the BMP-2 peptide did not synergize with the RGD cell-
binding domain within the context of these protein-based materials. Overall, these results 
suggest that incorporation of the BMP-2 peptide within the context of modular proteins is 








Protein-based biomaterials have emerged as promising tissue-engineered 
scaffolds. These materials, whose peptide sequences are precisely tuned at the molecular 
level, can be manufactured via solid-phase peptide synthesis (SPSS) or genetic 
engineering [59]. SPSS is a rapid method to produce short peptides (i.e., 35-40 amino 
acids) [60]. Compared to SPSS, genetic engineering allows researchers to create peptides 
and proteins with a wide range of sizes. In addition, the longer length of biomaterials 
produced by genetic engineering allows for facile incorporation of multiple 
functionalities through sequences such as structural (i.e., structural motifs or crosslinking 
sites) and bioactive domains (i.e., biochemical factors). For example, recent studies have 
utilized elastin-like [43, 61-63], resilin-like [57, 64, 65], and silk-like sequences [17, 66] 
as structural domains to provide mechanical properties suitable for specific tissue 
engineering applications. In addition, cell-binding sequences [57, 67, 68], heparin-
binding sequences [55], and matrix metalloproteinase degradation sites [64] have been 
incorporated as bioactive domains to elicit desired cellular responses. 
In particular, bioactive domains, such as cues to promote stem cell differentiation, 
that are incorporated directly into protein-based biomaterials act as material-based cues 
and have a number of advantages over soluble cues. Material-based cues remain at the 
target site, whereas soluble growth factors can diffuse away from the target and result in 
off-target effects. Thus, material-based differentiation cues would lead to more uniform 
differentiation compared to soluble cues, which could result in diffusion gradients and 
heterogeneous differentiation. In addition, soluble cues often are utilized at supra-
physiological concentrations, which causes side effects [69]. In contrast, attaching a cue 
to the material has the potential to lower the overall concentration by effectively 
increasing the local surface concentration. Furthermore, differentiation cues such as 
growth factors are often bound to the extracellular matrix, and material-based cues mimic 
this mode of presentation. 
This study investigates the use of material-based cues within the context of 
modular proteins that are designed to promote stem cells to produce bone matrix. Our 






domain (Figure 2.2.1). Our previous work demonstrates that similar materials are 
cytocompatible and that when the RGD cell-binding domain was incorporated within the 
protein-based materials, it promoted a faster rate of cell spreading compared to the 
sequence-scrambled negative control protein [57]. In the current work, we focus on 
incorporating a peptide sequence derived from bone morphogenetic protein-2 (BMP-2) 
growth factor and examining the ability of this modular protein to induce osteogenic 
differentiation. 
 
Figure 2.2.1 The full amino acid sequences of modular proteins used in this study. At the 
N-terminus, each protein has a T7 tag for protein identification, a heptahistidine tag (His 
tag) for identification or purification, and an enterokinase cleavage site for removal of the 
tags from the modular proteins. The bioactive domain (BA) (indicated by a black bar) 
contains one of the sequences listed in the box. For example, the bioactive domain of the 
RZ-BMP protein includes the BMP-2 peptide sequence, KIPKASSVPTELSAISTLYL. 
The RZ-scBMP and RZ-scRGD proteins serve as sequence-scrambled negative control 
proteins. 
Human mesenchymal stem cells (hMSCs) derived from the bone marrow have 
been extensively used in the field of tissue engineering because they are able to 
differentiate into multiple lineages such as bone, cartilage, muscle, and fat [70]. BMP-2 
growth factor is one of the most common cues for promoting differentiation of hMSCs 
into osteogenic lineages. It has been widely studied in vitro and in vivo in applications of 
bone tissue engineering and is being used clinically for bone regeneration [71].  
A short peptide sequence derived from the knuckle epitope of BMP-2 (hereafter 
referred to as the BMP-2 peptide) was synthesized and shown to have bioactivity similar 
to the full-length BMP-2 growth factor; the peptide specifically bound to two types of 
BMP receptors [23]. Further studies demonstrated that incorporating the BMP-2 peptide 
 M-MASMTGGQQMG-HHHHHHH-DDDDK-LDHMRTLS-(AQTPSSKQFGAPAQTPSSQFGAP) -KWADRHGGMR-       -LE



















in biomaterials induced osteogenic differentiation and ectopic bone formation [25, 26, 
72-74] and in vivo bone regeneration [75, 76]. In addition, there was a synergistic effect 
on osteogenic differentiation when the BMP-2 peptide and the RGD cell-adhesion 
sequence were both incorporated into scaffold materials [25, 27, 28]. Thus, these studies 
demonstrated that the BMP-2 peptide was active when incorporated within biomaterials, 
but these studies were limited to immobilizing or grafting the sequences on the materials. 
Here, we expand the utility of the BMP-2 peptide by demonstrating that it is 
bioactive within a new mode of ligand presentation (i.e., within the context of a 
genetically-engineered biomaterial). In particular, we utilize genetic engineering to 
incorporate the BMP-2 peptide directly into the backbone of our protein-based materials. 
Thus, the goal of this study was to investigate the ability of the BMP-2 peptide to 
promote osteogenic differentiation of hMSCs when presented within the context of the 
backbone of our genetically-engineered biomaterials. To accomplish our goal, we first 
used recombinant protein engineering to incorporate the BMP-2 peptide in modular 
proteins. Next, we evaluated the metabolic activity of human MSCs on our proteins. Last, 
we investigated whether genetically-engineered biomaterials incorporating the BMP-2 
peptide enhanced osteogenic differentiation and whether there were synergistic effects 
with the RGD cell-binding domain. 
2.3 Materials and Methods 
Materials: 
All materials used in this study were purchased from Sigma-Aldrich unless stated 
otherwise. 
Material Design: 
 The DNA constructs were cloned using the methods previously described [77]. In 
this study, the proteins consisted of ten repeats of a resilin-like sequence (RZ) derived 
from Anopheles gambiae and a bioactive domain (BA). The sequences for the BA 






Protein Expression and Purification: 
Protein expression was performed as previously described [57]. Briefly, E. coli 
strain BL21-CodonPlus (DE3)-RIPL (gift from Dr. Jo Davisson, Purdue University) 
containing the desired recombinant plasmid was inoculated in medium containing 35 
µg/mL kanamycin and 34 µg/mL chloramphenicol. Small-scale protein expression was 
conducted in 4 L baffled flasks, whereas large-scale protein expression was performed in 
a fermentor (BioFlo 110, 14 L capacity, New Brunswick). Expression was induced with 
isopropyl β-D-1-thiogalactopyranoside (IPTG, Denville Scientific).  
Proteins were purified by a salting-out and heating method as previously 
described [57, 77]. Briefly, cell pellets were resuspended in 8 M urea (pH 8.0), and cells 
were lysed using freeze-thaw cycles and sonication. After salting out undesired proteins, 
the modular proteins were precipitated with 20 (w/v) % ammonium sulfate. The re-
suspended proteins were heated at 80 °C for 10 min to remove undesired proteins. The 
solution was then dialyzed and freeze-dried. 
The molecular weight and purity of proteins were confirmed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Protein purity was 
determined by densitometry analysis using Image J software (NIH). The composition of 
purified proteins was confirmed by amino acid analysis (Purdue Proteomics Facility at 
the Bindley Bioscience Center). The bioactive domain sequences of the RZ-RGD and 
RZ-scRGD proteins were confirmed by peptide sequencing (Purdue Proteomics Facility 
at the Bindley Bioscience Center). Briefly, the proteins were digested with 
endoproteinase AspN, and the fragments were sorted by mass. Fragments from the C-
terminus containing the last 11 (RZ-RGD) or 12 (RZ-scRGD) amino acids were further 
fragmented into smaller pieces to determine each amino acid sequence. 
Surface Preparation: 
Protein surfaces were prepared 24 h before cell seeding. Proteins were dissolved 
in phosphate-buffered saline (PBS) at 1 mg/mL and adsorbed on tissue culture 
polystyrene (TCP) at 4 °C overnight. The next day, the surfaces were washed with PBS 






serum albumin (BSA) (fraction V) that had been heat-inactivated at 85 °C for 10 min. 
Blocking was performed for 30 min at room temperature, and then the surface was rinsed 
with PBS three times. The density of the proteins adsorbed on TCP was determined 
before cell differentiation studies (Figure 2.8.1).  
Cell Culture: 
To investigate cell responses on the proteins, hMSCs (Lonza) were cultured at 37 
°C and 5% CO2 in growth medium consisting of low-glucose Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (Lonza), 100 
U/mL penicillin, 100 mg/mL streptomycin (Invitrogen), and 10 ng/mL basic fibroblast 
growth factor (bFGF, R&D Systems, courtesy of the National Cancer Institute Preclinical 
Repository). Cells were seeded at a density of 5,000-6,000 cells/cm
2
 and sub-cultured 
after they reached 60-80% confluence.  
To investigate the bioactivity of our proteins, hMSCs were seeded at a density of 
3,100 cells/cm
2 
on TCP or proteins. After the cells reached 70-85% confluence, they were 
cultured in osteogenic medium consisting of growth medium without bFGF and 
supplemented with 100 nM dexamethasone, 50 µM ascorbic acid 2-phosphate, and 10 
mM glycerol-2-phosphate disodium salt hydrate. The medium was replaced every three 
days. All experiments were performed using cells at passages 3-5. 
Cellular Metabolic Activity: 
Cellular metabolic activity on proteins was measured by monitoring the reduction 
of the tetrazolium salt WST-1 (GBioscience). Briefly, 10 µL of the reagent was added to 
each well containing 100 µL of the growth medium, and cells were incubated for 4 h at 
37 °C. The absorbance of the medium was measured at 440 nm by a SpectraMax M2
e
 
(Molecular Devices) and normalized by the absorbance reading at 600 nm. At each time 
point, metabolic activity was determined as the percentage relative to the positive control 







Alkaline Phosphatase (AP) Activity: 
 Culture medium was replaced 24 h prior to cell lysis to prevent serum starvation. 
Cells were washed with PBS once and lysed in 0.1 (v/v) % triton in water (pH 7.4) for 15 
min at room temperature. Collected cells were frozen at -80 °C before being assayed. 
Frozen cells were thawed and centrifuged, and the supernatant was collected. For DNA 
quantification, 50 µL of Hoechst 33258 solution (0.7 µg/mL in 50 mM Tris, 100 mM 
NaCl, and 0.1 mM EDTA, pH 7.4) was mixed with an equal amount of the supernatant, 
and the fluorescence was measured with an excitation at 340 nm and emission at 465 nm. 
Calf thymus DNA was used as a standard. For assessment of AP activity, 50 µL of the 
supernatant was combined with 50 µL of p-nitrophenol phosphate solution (10 mg/mL in 
0.1 M glycine and 1 mM MgCl2, pH 9.6) and incubated at 37 °C for 150 min. The 
absorbance was measured at 405 nm, and p-nitrophenol (Alfa Aesar) was used as a 
standard. AP activity was normalized by the amount of DNA and incubation time. Three 
or four replicates of each group were examined. 
Calcium Deposition: 
At each time point, cells were fixed with 4 (w/v) % paraformaldehyde in PBS at 
room temperature for 15 min and then washed with Milli-Q water (Millipore) three times. 
Cells were stained with 40 mM Alizarin red S (pH 4.1) for 40 min at room temperature 
with gentle shaking. After Alizarin red S staining, cells were washed with Milli-Q water 
five times to remove excess dye. The plates were stored at -20 °C until imaging and dye 
extraction. All images were obtained at the same time by using a 4x objective on a Nikon 
Ti-EC-1 Plus microscope. 
Calcium deposits were quantified by extracting Alizarin red S from the stained 
monolayer as previously described.[78] Briefly, stained cells were incubated with 10 
(v/v) % acetic acid for 30 min with gentle shaking. The cell solution was heated at 85 °C 
for 10 min and then incubated on ice for 5 min. Following centrifugation, the supernatant 
was neutralized with 1 (v/v) % ammonium hydroxide to adjust the pH between 4.1 and 






405 nm. Alizarin red S solutions in acetic acid (pH 4.1-4.5) were used as a standard. 
Three to six replicates per group were examined. 
Quantitative Reverse Transcription–Polymerase Chain Reaction (qPCR): 
The medium was replaced 24 h before sample collection to prevent serum 
starvation. Samples were processed and analyzed as previously described [79]. After 
removal of genomic DNA, the amount of purified RNA was measured on a Nanodrop 
spectrophotometer (ND 1000, Thermo Scientific). At least 0.5 µg RNA was used to 
produce complementary DNA. For qPCR, all individual samples were run in duplicate 
(day 7 and 11) or triplicate (day 4). The primer sequences for runt-related transcription 
factor 2 (Runx2), AP, type I collagen (type I col), osteopontin (OPN), bone sialoprotein 
(BSP), type II collagen (type II col), and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) were obtained from references or designed using Primer-Blast on the National 
Institutes of Health website (Table 2.8.1). The relative gene expression level was 
calculated by the ∆∆ Ct method; GAPDH was used as the housekeeping gene, and 
expression levels were determined relative to the positive control (TCP). There were four 
to six replicates per group. 
Statistical Analysis: 
All data are represented as mean ± standard deviation. Normality and 
homogeneity of variance were confirmed by Shapiro-Wilk and Levene’s modified tests, 
respectively. For data that passed both tests, one-way analysis of variance (ANOVA) was 
performed. Dunnett’s test was performed at each time point to determine significant 
differences between the control (TCP) and an experimental group. Statistical differences 
between experimental groups were also determined by Tukey’s post hoc test. Data 
showing unequal variances (days 9 and 11 in Figure 2.4.3) were analyzed by a Box-Cox 
transformation [80]. Data with a non-normal distribution (day 9 in Figure 2.4.4B) were 
evaluated by a non-parametric Kruskal-Wallis test. All statistical analyses were 
performed using Statistical Analysis Software (SAS, version 9.2), and values of p < 0.05 







Material Design, Production, and Characterization:  
 The full amino acid sequences of proteins used in this study are shown in Figure 
2.2.1. Each protein consists of a structural domain to provide mechanical integrity and a 
bioactive domain to promote cell differentiation. Ten repeats of a resilin-like consensus 
sequence (RZ) derived from A. gambiae, AQTPSSQYGAP, comprised the structural 
domain. The bioactive domain included either the BMP-2 peptide (RZ-BMP proteins) or 
the cell-binding sequence (RZ-RGD proteins). Proteins containing scrambled versions of 
the BMP-2 peptide (RZ-scBMP proteins) or the cell-binding sequence (RZ-scRGD 
proteins) served as negative control proteins whose amino acid composition matched 
those of the RZ-BMP and RZ-RGD proteins, respectively. Our previous work describes 
the manufacture and initial characterization of the RZ-RGD and RZ-scRGD proteins [57]. 
Thus, this work will describe the production and initial investigation of the RZ-BMP and 
RZ-scBMP proteins. 
 
Figure 2.4.1 Successful purification of RZ-BMP and RZ-scBMP proteins. Proteins were 
analyzed on an SDS-PAGE gel and appeared close to the expected molecular weight of 
18.6 kDa. Densitometry analysis confirmed that the protein samples were > 90% pure. 
The average yields of purified RZ-BMP and RZ-scBMP proteins in small- and 
















analysis confirmed that the RZ-BMP and RZ-scBMP proteins ran near the expected 
molecular weight of 18.6 kDa and that the proteins were > 90% pure (Figure 2.4.1). 
Amino acid analysis confirmed the compositions of the RZ-BMP and RZ-scBMP 
proteins, and the observed value of each component was within 1 mol % of the 
anticipated value (Table 2.8.1). Circular dichroism (CD) spectroscopy demonstrated that 
the RZ-BMP and RZ-scBMP proteins have an unordered structure (Figure 2.8.2 The 
secondary structure of modular proteins evaluated by CD spectroscopy. The results 
demonstrated that the RZ-BMP and RZ-scBMP proteins have an unordered structure. CD 
spectra were measured using protein solutions at 0.2 mg/mL in Milli-Q water at room 
temperature.), which is similar to the structure of the RZ-RGD and RZ-scRGD proteins 
previously reported [57]. 
Human MSC Metabolic Activity on Modular Proteins: 
Cellular metabolic activity on proteins was assessed by the WST-1 assay ( 
Figure 2.4.2). After one day of seeding, it appeared as if fewer cells had attached 
to our protein surfaces compared to TCP. In particular, the number of hMSCs on RZ-
BMP and RZ-scBMP proteins was 71 ± 11 and 71 ± 6 %, respectively, compared to those 
on the positive control (TCP). However, 2-4 days after seeding, there was no difference 
in the metabolic activity of cells grown on TCP or the proteins. These results suggest that 
the RZ-BMP and RZ-scBMP proteins are cytocompatible and support hMSC 
proliferation at a rate similar to TCP. In subsequent differentiation studies, differentiation 
medium was added 4 days after seeding, at which time cell number and metabolic 







Figure 2.4.2 Human MSC metabolic activity on the RZ-BMP and RZ-scBMP proteins. 
At each time point, cellular metabolic activity was evaluated by the WST-1 assay, and the 
results are presented relative to the positive control (TCP). Cells on all three surfaces had 
statistically equivalent metabolic activity 2-4 days after seeding. These results suggest 
that the RZ-BMP and RZ-scBMP proteins supported cell proliferation. Data are 
represented as the average ± standard deviation of six replicates. * indicates p < 0.05 
compared to the positive control (TCP) at that time point as determined by Dunnett’s test. 
Presenting the BMP-2 Peptide within the Context of Genetically-engineered Proteins 
Accelerates Osteogenic Differentiation: 
In examining cell differentiation on our proteins, our first objective was to 
determine whether incorporating the BMP-2 peptide within the context of protein-based 
biomaterials (RZ-BMP) would enhance osteogenic differentiation compared to control 
(TCP). Second, we evaluated whether there were synergistic effects when the BMP-2 
peptide and the RGD sequence were individually incorporated within the backbone of the 
protein-based materials (RZ-BMP and RZ-RGD proteins, respectively). To accomplish 
this goal, we included two additional surfaces in our study – a 50:50 mixture of RZ-BMP 
and RZ-scRGD proteins (designated RZ-BMP+RZ-scRGD) and a 50:50 mixture of RZ-
BMP and RZ-RGD proteins (designated RZ-BMP+RZ-RGD). To characterize cell 
response on proteins, we examined markers of osteogenic differentiation such as AP 



























AP activity, which is an early marker of osteogenic differentiation, was 
characterized by measuring the hydrolysis of p-nitrophenyl phosphate substrate (Figure 
2.4.3). At all time points, the AP activity of cells cultured on RZ-BMP was higher than 
on the positive control (TCP). Compared to TCP, the RZ-BMP proteins induced a 2-fold 
increase at early time points (4 and 7 days) and a 3-fold increase at later time points (9 
and 11 days). However, cells cultured on the sequence-scrambled negative control RZ-
scBMP protein did not enhance AP activity compared to cells on TCP. Of particular note, 
cells on RZ-BMP had statistically higher AP activity compared to cells on RZ-scBMP at 
all time points (p < 0.05, Tukey’s post hoc test). Therefore, our results indicate that the 
RZ-BMP proteins effectively enhance AP activity in a sequence-specific manner. 
 
Figure 2.4.3 Presenting the BMP-2 peptide within the context of genetically-engineered 
materials (RZ-BMP or RZ-BMP+RZ-scRGD proteins) enhances the AP activity of cells. 
Compared to cells on TCP, cells grown on RZ-BMP or RZ-BMP+RZ-scRGD proteins 
showed increased AP activity at all time points, whereas those on RZ-scBMP or RZ-
BMP+RZ-RGD proteins did not. AP activity was normalized by the DNA amount and 
reaction time. Error bars indicate the standard deviation of 3-4 replicates. * indicates p < 
0.05 compared to TCP at that time point as determined by Dunnett‘s test. 
Cells on RZ-BMP+RZ-scRGD proteins had statistically higher AP activity 
compared to cells on TCP at all time points. Also, the AP activity of cells on RZ-











































0.05, Tukey’s post hoc test). Interestingly, the AP activity of cells on RZ-BMP+RZ-RGD 
was not significantly different from those on TCP. Furthermore, from 4 to 9 days of 
differentiation, cells cultured on RZ-BMP+RZ-RGD showed a significantly lower AP 
activity than those on either RZ-BMP or RZ-BMP+RZ-scRGD (p < 0.05, Tukey’s post 
hoc test).  
Next, we carried out Alizarin red S staining to examine calcium deposition 
(mineralization) of cells cultured on the five different surfaces, and the extent of calcium 
deposition was quantified by extracting the dye from the stained monolayer (Figure 2.4.4). 
After 9 days of differentiation, no mineralization was observed. However, the amount of 
calcium deposited increased from 9 to 11 days of differentiation. After 11 days of 
differentiation, cells cultured on RZ-BMP or RZ-BMP+RZ-scRGD exhibited a 
significant 3-fold increase in calcium deposition compared to those on TCP. However, 
the RZ-BMP+RZ-RGD proteins did not enhance calcium deposition.  
 
Figure 2.4.4 Increased calcium deposition by cells grown on modular proteins. (A) 
Bright-field images of stained cell monolayers after 11 days of differentiation on TCP or 
the proteins. Cells were stained with Alizarin red S, and pictures from three separate 
wells are shown for each surface. Scale bar represents 250 µm. (B) Quantification of 
Alizarin red S (ARS) staining (n=4-6) was performed by extracting dye from the stained 
monolayers. Compared to cells grown on TCP, cells on RZ-BMP and RZ-BMP+RZ-
scRGD proteins showed increased calcium deposition at 11 days of differentiation. * 
indicates p < 0.05 compared to TCP at that time point as evaluated by Dunnett‘s test. 
Of note, cells grown on the RZ-scBMP proteins showed statistically higher 













































that there was more RZ-scBMP adsorbed to the surfaces compared to RZ-BMP, RZ-
BMP+RZ-scRGD, or RZ-BMP+RZ-RGD (Figure 2.8.1B). Due to the higher RZ-scBMP 
protein density, the increased number of non-specific interactions with the resilin portion 
or with the amino acids within the scrambled domain may have resulted in statistically 
higher calcium deposition on RZ-scBMP compared to TCP. 
To ensure that our results can be attributed to protein surfaces and are not due to 
protein desorbing from the surface, we incubated the RZ-BMP surfaces with medium and 
used this pre-conditioned medium in cell differentiation studies. The medium pre-
conditioned on the RZ-BMP proteins did not accelerate osteogenic differentiation 
compared to the medium pre-conditioned on TCP (Figure 2.8.3). 
Finally, we examined the gene expression level of osteogenic markers by qPCR. 
Runx2 is a transcriptional factor involved in osteogenic lineage commitment, whereas AP 
and type I col are early- and mid-stage osteogenic markers, respectively. Compared to 
control (TCP), cells on RZ-BMP had higher expression levels of Runx2 at 11 days and 
type I col at 7 and 11 days (Figure 2.4.5). Although the AP activity was elevated at all 
time points when cells were cultured on RZ-BMP (Figure 2.4.3), no increases in gene 
expression of AP were observed (Figure 2.4.5). Cells on the RZ-scBMP proteins 








Figure 2.4.5 Increased expression levels of bone-related genes by cells grown on modular 
proteins. Gene expression was measured by qPCR. The relative expression levels of 
Runx2, AP, and type I col of cells grown on TCP or the proteins were normalized by 
GAPDH (a housekeeping gene) and are reported relative to the control (TCP) at each 
time point. Data (n=4-6) are represented as mean ± standard deviation. * indicates p < 
0.05 compared to the positive control (TCP) at each time point as assessed by Dunnett‘s 
test. 
The expression of Runx2 and type I col was enhanced on the RZ-BMP+RZ-RGD 
proteins at all time points compared to control (TCP). Furthermore, cells on RZ-
BMP+RZ-RGD had increased AP levels on day 4. Cells on RZ-BMP+RZ-scRGD had 
responses similar to those on RZ-BMP+RZ-RGD except that Runx2 levels were not 
enhanced on day 4. 
We also analyzed OPN and BSP, which are late markers of osteogenic 
differentiation, but no differences between groups were observed (Figure 2.8.4). To 
confirm whether cell differentiation on proteins is osteogenic-specific, we assessed the 
expression level of type II col, which is commonly associated with cartilage matrix. The 
type II col levels on all proteins were statistically equivalent at all time points (Figure 
2.8.4), suggesting that cells are not undergoing cartilage differentiation. 
2.5 Discussion 
The full-length BMP-2 growth factor is a potent cue for promoting osteogenic 
differentiation and is approved by the Food and Drug Administration (FDA) to be used 
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growth factor on bone regeneration, its use in clinical applications in soluble form (e.g., 
addition of soluble BMP-2, adsorption or encapsulation of BMP-2 in scaffold materials) 
is hampered by several factors. First, the production of recombinant human BMP-2 
(rhBMP-2) is not yet cost-effective [81]. Mammalian cells result in low yields of rhBMP-
2, and rhBMP-2 produced in bacteria (i.e., E. coli) is usually found in inclusion bodies, 
which complicates purification due to the additional steps of solubilization and refolding 
[82, 83]. Second, the effective clinical concentration of soluble BMP-2 is often supra-
physiological (e.g., several milligrams) [84], which causes adverse effects such as soft-
tissue swelling [85] and inflammation [86]. Third, rhBMP-2 has a short half-life and 
retention time [71]. 
An attractive alternative to using soluble full-length BMP-2 growth factor is to 
incorporate the short BMP-2 peptide [23], which is known to promote bone regeneration, 
into a scaffold material. The shorter length reduces the production cost. Moreover, 
attaching the peptide to the material potentially lowers the overall concentration because 
of the increased local concentration and because the peptide does not diffuse away from 
the target site. This strategy has resulted in enhanced osteogenic differentiation and bone 
regeneration in biomaterials that present the BMP-2 peptide through covalent 
immobilization [25, 72, 74] or specific binding on the surface of the material [26, 75]. 
However, none of these studies have explored directly incorporating the BMP-2 peptide 
within the material backbone and examined its bioactivity within the context of a 
genetically-engineered biomaterial.   
Our approach enables multiple functionalities to be incorporated within the 
backbone of a single material. Because the amino acid sequence can be tightly controlled 
at the molecular level, genetic engineering allows us to precisely engineer materials to 
elicit desired cell responses [59]. In addition, given that the bioactive cues are 
incorporated into the backbone of the materials, our approach simplifies material 
preparation and characterization because it eliminates the additional steps needed to 
immobilize the cues on the material and quantify the ligand density. 
Our modular proteins supported hMSC proliferation (Figure 2.4.2), and the BMP-






control (TCP) (Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5). When seeded on the RZ-
BMP proteins, hMSCs showed higher levels of AP activity, calcium deposition, and gene 
expression of Runx2 and type I collagen compared to cells on TCP. Cells on RZ-BMP 
surfaces did not show higher AP gene expression than those on TCP. Given that mRNA 
is regulated upstream of protein translation and protein activity and that previous 
literature shows that AP expression levels are transient [87, 88], one potential reason for 
this discrepancy is that the time points we selected did not capture the transient increase 
in AP gene expression on RZ-BMP. In fact, AP enzyme activity on RZ-BMP surfaces 
was already elevated at day 4 in our results, and we postulate that AP gene expression on 
RZ-BMP may have increased and reached a peak prior to this time point. The pattern of 
AP gene expression peaking at an earlier time point than AP enzyme activity has been 
previously observed in literature [89]. The surface density of the BMP-2 peptide within 




Figure 2.8.1B) was 
similar to the density from previous studies when the peptide was grafted on materials 
(5.2-120 pmol/cm
2 
[25, 27, 90]). The bioactivity of the RZ-BMP proteins is likely to be 
osteogenic-specific, as there was no increase in the expression level of a cartilage marker 
(type II col) at all time points (Figure 2.8.4). Moreover, we confirmed that the bioactivity 
of the RZ-BMP proteins did not result from proteins desorbed from the plate (Figure 
2.8.3). Thus, these results demonstrate the bioactivity of the BMP-2 peptide within the 
context of our modular proteins and the potential of our genetically-engineered 
biomaterials for accelerating osteogenic-specific differentiation. 
The RZ-scBMP proteins, which serve as sequence-scrambled negative control 
proteins, increased a couple of osteogenic markers. Specifically, calcium deposition at 
day 11 and gene expression of type I collagen on day 7 were increased compared to TCP. 
We hypothesize that these effects may be due to the higher protein density of RZ-scBMP 
compared to other proteins (Figure 2.8.1B). In fact, several experiments which sought to 
use the same density of RZ-BMP and RZ-scBMP confirmed that the only the RZ-BMP 
and not the RZ-scBMP surfaces promote increased calcium deposition compared to TCP 
(Figure 2.8.5). Another possibility is that Alizarin red S staining is a rather unspecific 






response on RZ-BMP proteins, cells on RZ-scBMP proteins did not enhance as many 
osteogenic markers. From these results, we conclude that the authentic BMP-2 peptide 
sequence elicits a more robust response compared to the scrambled sequence. Thus, the 
cells appear to respond to the RZ-BMP proteins in a sequence-specific manner. 
Interestingly, it appeared that the RZ-BMP+RZ-scRGD proteins induced 
osteogenic differentiation similar to that of the RZ-BMP proteins. Specifically, the AP 
activity and calcium deposition were statistically equivalent between the two groups 
(Figure 2.4.3 and Figure 2.4.4, p < 0.05, Tukey’s post hoc test). In addition, the RZ-
BMP+RZ-scRGD proteins upregulated more osteogenic genes than the RZ-BMP proteins 
did. In particular, the RZ-BMP+RZ-scRGD surfaces upregulated the gene expression of 
Runx2 (day 7), AP (day 4), and type I col (day 4) (Figure 2.4.5), whereas the RZ-BMP 
proteins did not. Overall, it appeared that the RZ-BMP and RZ-BMP+RZ-scRGD 
proteins both resulted in enhanced osteogenic differentiation compared to TCP.  
We note that the density of the BMP-2 peptide was significantly lower on the RZ-
BMP+RZ-scRGD surface than the RZ-BMP surface. In particular, the total amount of 
proteins was approximately equal on the RZ-BMP and RZ-BMP+RZ-scRGD surfaces 
(Figure 2.8.1B). But, because the RZ-BMP+RZ-scRGD protein surface is a 50:50 
mixture, the BMP-2 peptide density on the RZ-BMP+RZ-scRGD surfaces is ~33 
pmol/cm
2
, which is almost half the density on the RZ-BMP proteins (69 pmol/cm
2
). 
Taken together, these results suggest that peptide densities of 33-69 pmol/cm
2
 are 
sufficient to promote osteogenic differentiation and that, within this range, the density of 
the bioactive ligand (i.e., the BMP-2 peptide sequence) did not significantly influence the 
extent of osteogenic differentiation. As a comparison, full-length BMP-2 growth factor 
immobilized on biomaterials promotes osteogenic differentiation at a density of 1.15-15.4 
pmol/cm
2 
[91, 92], which are lower than the density of the BMP-2 peptide in our study.  
In our study, a combination of the BMP-2 peptide and RGD did not display 
synergistic effects on differentiation. In fact, it appeared as if the RZ-BMP+RZ-RGD 
surfaces were less potent than either the RZ-BMP or RZ-BMP+RZ-scRGD surfaces in 
promoting osteogenic differentiation. Although the RZ-BMP+RZ-RGD surfaces did 






translate into higher AP activity or calcium deposition compared to TCP (Figure 2.4.3 
and Figure 2.4.4). To verify these results, we confirmed that the amino acid sequences of 
the bioactive domains in the RZ-RGD and RZ-scRGD proteins were correct by analyzing 
both proteins through peptide sequencing (see Materials and Methods 2.3). 
Previous studies report conflicting results as to whether the BMP-2 peptide and 
the RGD cell-binding domain have a synergistic effect on osteogenic differentiation [25, 
27, 28, 93].
 
Some studies reported that when the RGD and BMP-2 peptides were grafted 
onto materials, higher osteogenic differentiation was observed compared to materials 
containing only the BMP-2 peptide [25, 28]. Moore et al. investigated the effect of 
concentration of both peptides on osteogenic differentiation and reported the synergistic 
enhancement on BSP expression only at a total concentration of 130 pmol/cm
2
 (i.e., 65 
pmol/cm
2
 for each peptide) [27]. However, Koepsel et al. observed that the RGD and 
BMP-2 peptides did not have a significant effect on AP activity [93]. Potential reasons 
for the conflicting results regarding synergy could be due to differing peptide densities or 
modes of ligand presentation within the studies.  
Last, given that the RZ-BMP+RZ-scRGD surface promoted osteogenic 
differentiation but the RZ-BMP+RZ-RGD surface did not, it appeared as if the presence 
of the RGD cell-binding domain suppressed the protein expression and calcium 
deposition elicited by the BMP-2 peptide sequence. There are several potential reasons 
that may contribute to this result. First, the RGD domain in the RZ-BMP+RZ-RGD 
surfaces may delay osteogenic differentiation due to strong cell adhesion to the surfaces. 
Previous studies demonstrate that RGD-modified materials resulted in a slower rate of 
osteogenesis than unmodified ones [94, 95]. Second, when cells are cultured on the RZ-
BMP+RZ-RGD surfaces, the enhanced osteogenic differentiation elicited by the BMP-2 
peptide could be suppressed by integrin binding to the RGD domain. The RGD sequence, 
which is derived from fibronectin, interacts primarily with the αvβ3 and α5β1 integrins [96, 
97], which are expressed on the membrane of hMSCs [98, 99] and human osteoblast-like 
cells [100]. In our study, it is likely that only the αvβ3 integrins bind the RGD domain in 
RZ-RGD because α5β1 binding requires both the RGD sequence and the PHSRN synergy 






integrins promote or suppress osteogenic differentiation [102-107]. However, some 
studies have observed that osteogenic differentiation was suppressed by αvβ3 integrin 
binding, and the inhibition was rescued by blocking the αvβ3 integrins [103, 105]. In 
addition, RGD-functionalized surfaces that support αvβ3 binding retarded osteogenic 
differentiation [106]. Thus, it is possible that αvβ3 integrin binding to the RGD domain in 
RZ-RGD resulted in inhibition of osteogenic differentiation elicited by the BMP-2 
peptide in RZ-BMP. However, further investigation is needed to identify the mechanism 
that contributes to the cell response observed on the RZ-BMP+RZ-RGD surface.  
Taken together, our results demonstrate that the modular protein design provides a 
new strategy for incorporating the BMP-2 peptide in materials. We found that the BMP-2 
peptide in modular proteins accelerated osteogenic differentiation of hMSCs and induced 
robust osteogenic differentiation in a sequence-specific manner.  
2.6 Conclusions 
This work successfully demonstrated a new strategy to incorporate the BMP-2 
peptide in biomaterials for applications in bone tissue engineering. By using genetic 
engineering, a strategy that allows us to precisely control material properties, we 
incorporated the BMP-2 peptide into the backbone of our protein-based biomaterials. We 
found that, within the context of our modular proteins, the BMP-2 peptide was bioactive 
and accelerated osteogenic differentiation in a sequence-specific manner. In addition, our 
results showed that the density of the BMP-2 peptide (i.e., 33 pmol/cm
2
 on RZ-
BMP+RZ-scRGD or 69 pmol/cm
2
 on RZ-BMP) did not affect the extent of cell 
differentiation. Within the context of our modular proteins, the BMP-2 peptide did not 
synergize with the RGD cell-binding sequence. Overall, our results suggest that 
incorporation of bioactive peptides (the BMP-2 peptide in this study) into genetically-
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2.8 Supporting Information 
Circular Dichroism (CD): 
Protein solutions (0.2 mg/mL in Milli-Q water) were scanned on a Jasco-815 
Circular Dichroism spectrometer at room temperature using a 0.1 cm path length. The 
spectrum is an average of three scans. 
Surface Quantification: 
The density of proteins adsorbed on TCP was quantified by using the QuantiPro 
BCA assay kit. Briefly, 50 µL of PBS was added to the protein surface and mixed with an 
equal amount of the reagent. After incubation for 1 h at 60 °C, the absorbance at 562 nm 
was measured. A standard curve was created using the individual proteins in PBS. Five or 
six replicates per group were examined.  
Cell Culture: 
 To investigate the effect of proteins that may be desorbed from the plate, cells 






were adsorbed on TCP as described in the main text. Next, medium (low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) containing 100 U/mL penicillin and 100 
mg/mL streptomycin (Invitrogen)) was incubated on either TCP or RZ-BMP surfaces for 
three days at 37 °C and 5% CO2. The medium was then supplemented with 10% fetal 
bovine serum (Lonza), 100 nM dexamethasone, 50 µM ascorbic acid 2-phosphate, and 10 
mM glycerol-2-phosphate disodium salt hydrate. The osteogenic pre-conditioned medium 
was added to cells grown on TCP after they reached a confluence of 70-85%. The pre-
conditioned medium was replaced every three days.  
Statistical Analysis: 
All data are represented as mean ± standard deviation. All data passed normality testing 
by Shapiro-Wilk test and homogeneity of variance by Levene’s modified test. A one-way 
(Figure 2.8.1B and Figure 2.8.4) or two-way (Figure 2.8.1A) analysis of variance 
(ANOVA) was performed. To determine significant differences between groups, a 
Tukey’s post hoc test (Figure 2.8.1), a two-tailed t-test (Figure 2.8.3), or Dunnett’s test 
was performed. All statistical analyses were performed using Statistical Analysis 







Table 2.8.1 Primer sequences for quantitative reverse transcription-polymerase chain 
reaction 




Runx2 NM004348.3 F CTTCAAGGTGGTAGCC
CTCGGAGAG 
97% 106 Designed 
R AACAGCAGAGGCATTC
CGGAGC 
AP NM00478.4 F GTACTGGCGAGACCAA
GCGCAA 
96% 110 Designed 
R CACCCATCCCATCTCC
CAGGAACA 
Type I col NM000088 F TCTGACTGGAAGAGTG
GAGAGTACTGG 
102% 139 [79] 
R ACCAGTTCTTCTGGGC
CACACT 
OPN NM001040060.1 F GTGGGAAGGACAGTTA
TGAAACG 
96% 134 [108] 
R CTGACTATCAATCACA
TCGGAAT 
BSP NM004967 F GGGCAGTAGTGACTCA
TCCGAAG 
96% 164 [109] 
R CTCCATAGCCCAGTGT
TGTAGCAG 
Type II col NM001844.4 F GGCAATAGCAGGTTCA
CGTACA 
96% 79 [110] 
R CGATAACAGTCTTGCC
CCACTT 
GAPDH NM002046.3 F ACAGTCAGCCGCATCT
TCTT 








Table 2.8.2 Amino acid analysis of RZ-BMP and RZ-scBMP proteins 








ASX 4.00 3.67 3.37 
SER 13.36 13.95 14.61 
GLX 13.68 13.71 13.48 
GLY 8.43 8.40 8.43 
HIS 4.48 4.81 5.06 
ARG 2.32 2.10 1.69 
THR 7.62 7.68 7.87 
ALA 13.62 13.48 13.48 
PRO 11.87 12.37 12.36 
TYR 0.66 0.63 0.56 
VAL 1.28 0.83 0.56 
MET 2.74 3.00 3.37 
LYS 5.07 5.05 5.06 
ILE 1.55 1.16 1.12 
LEU 3.70 3.40 3.37 
PHE 5.62 5.77 5.62 







Figure 2.8.1 Adsorbed protein density. (A) Adsorption isotherms show the adsorbed 
protein density as a function of concentrations of the protein solutions. A two-way 
ANOVA was used to determine whether protein identity or concentration had a 
significant effect on adsorbed protein density. The protein identity did not affect adsorbed 
protein density, whereas the concentration did. The adsorbed protein density increased at 
a concentration of 0.5 mg/mL and saturated at a concentration of 1 mg/mL. Therefore, in 
this work, we chose a protein concentration of 1 mg/mL to prepare our surfaces. Data 
(n=3-5) are represented as the mean ± standard deviation. (B) For the cell differentiation 
studies shown in Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5, the density of the adsorbed 
protein surfaces was quantified. A one-way ANOVA and Tukey‘s post hoc test were 
performed, and different letters denote significant differences (p < 0.05) between groups. 
The RZ-BMP, RZ-BMP+RZ-scRGD, and RZ-BMP+RZ-RGD surfaces had statistically 
equivalent protein densities, whereas the RZ-scBMP surface had a 1.6-fold higher protein 






































































Figure 2.8.2 The secondary structure of modular proteins evaluated by CD spectroscopy. 
The results demonstrated that the RZ-BMP and RZ-scBMP proteins have an unordered 
structure. CD spectra were measured using protein solutions at 0.2 mg/mL in Milli-Q 
water at room temperature. 
 
Figure 2.8.3 The effect of protein desorption on osteogenic differentiation. Human MSCs 
on TCP were cultured in pre-conditioned medium that had been incubated on TCP (pre-
TCP) or on RZ-BMP protein surfaces (pre-RZ-BMP). Cells were stained with Alizarin 
red S and the amount of dye was quantified. Compared to cells cultured in pre-TCP 
medium, cells cultured in pre-RZ-BMP medium did not show an increase in calcium 
deposition. These results demonstrate that RZ-BMP protein desorption did not contribute 
to the results observed in Figure 2.4.2, Figure 2.4.3, Figure 2.4.4, and Figure 2.4.5. The 
error bars indicate the standard deviation of six replicates. A two-tailed t-test was 
performed to determine statistical difference between two groups. * represents p < 0.05 





























































Figure 2.8.4 Relative mRNA expression levels of osteopontin (OPN), bone sialoprotein 
(BSP), and type II collagen (type II col) measured by qPCR. Expression levels were 
normalized by GAPDH (a housekeeping gene) and are reported relative to the control 
(TCP) at each time point. Data (n=4-6) are represented as mean ± standard deviation. 
Dunnett‘s test indicated that, at all time points, there were no statistical differences 
between each group and the control (TCP). 
 
Figure 2.8.5 Accelerated calcium deposition on RZ-BMP surfaces. Cells were stained 
with Alizarin red S at three time points during osteogenic differentiation, and the amount 
of dye was quantified. At 11 and 13 days, cells grown on the RZ-BMP surfaces exhibited 
statistically higher calcium deposition than cells on TCP. * denotes p < 0.05 compared to 
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CHAPTER 3. PROTEIN-ENGINEERED MICROENVIRONMENTS CAN PROMOTE 
ENDOTHELIAL DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS 
IN THE ABSENCE OF EXOGENOUS GROWTH FACTORS 
This chapter consists of a manuscript by Kim Y and Liu JC, prepared for submission in 
2014. 
3.1 Abstract 
Peripheral artery disease often requires treatments with vascular grafts for vessel 
reconstruction. Endothelialization of the vascular grafts is important to achieve long-term 
patency because endothelial cells regulate thrombosis, inflammation, and growth of 
smooth muscle cells. One potential source of endothelial cells is human mesenchymal 
stem cells (hMSCs), which can be routinely differentiated towards the endothelial lineage 
using exogenous growth factors such as VEGF. However, there are few studies that 
investigate the effect of materials on endothelial differentiation in the absence of growth 
factors. This study demonstrates that exogenous growth factors are not needed to achieve 
endothelial differentiation of hMSCs and that protein-based microenvironments promote 
endothelial differentiation. Cells grown on the protein-engineered microenvironments 
were viable, had normal metabolic activity, and displayed increased endothelial-specific 
markers and endothelial function. In particular, cells cultured on our proteins formed 
networks that were statistically equivalent to positive control cells. We confirmed that 
enhanced endothelial differentiation on our proteins is protein-specific, as a non-
interactive protein did not show similar enhancements. Thus, our protein-based materials 








Peripheral artery disease is caused by excessive deposition of plaques on the inner 
surface of an artery. Approximately 8.5 million Americans currently suffer from the 
disease, and by 2050, the projected number of patients is expected to be 19 million [89]. 
To treat the disease, a surgical bypass or vessel replacement is often required if the vessel 
is severely blocked with plaques. Replacement with autologous artery or vein from the 
patient‘s body is the current gold standard for treatment. However, the availability of 
donor vessels may be limited due to vascular disease or previous harvest. Synthetic graft 
materials such as poly(ethylene terephthalate) (PET) or expanded 
poly(tetrafluoroethylene) (ePTFE) are widely employed alternatives [12], but their 
performance is unsatisfactory in small-diameter vessels (i.e., less than 6 mm) such as 
peripheral arteries. After five years, the grafts showed poor performance and a low 
patency rate (i.e., 30 %) due to thrombosis and intimal hyperplasia [112-115]. These 
failures resulted from the absence of a confluent endothelial cell layer on the interior of 
the graft and a mismatch in mechanical properties between the graft and surrounding 
tissue. 
The lack of endothelium remains one of the major challenges in achieving a high 
patency rate in small-diameter vascular grafts. Because endothelial cells regulate 
inflammation, thrombosis, and growth of smooth muscle cells, one approach has been to 
increase patency rates by pre-seeding endothelial cells on small-diameter vascular grafts. 
One clinical study demonstrated that ePTFE grafts seeded with autologous endothelial 
cells resulted in significantly higher patency rates of 85 and 65% after 3 and 7 years, 
respectively, compared to non-endothelialized grafts with rates of 50 and 16% [116]. 
Another study found that grafts seeded with endothelial-like cells, which were obtained 
by differentiating mesenchymal stem cells, had increased patency and tissue regeneration 
in a canine model compared to grafts prepared without cell seeding [117]. 
Cell source is an important consideration when designing strategies to establish an 
endothelial layer on vascular grafts. Autologous endothelial cells already have the desired 
functional characteristics and avoid immunogenicity issues. However, autologous 






an alternative, bone marrow mesenchymal stem cells (MSCs) have emerged as an 
attractive source because they have a high proliferation capacity and can be differentiated 
into endothelial-like cells. Also, aspiration of MSCs from bone marrow is less invasive 
compared to blood vessel biopsies, which are used to obtain mature endothelial cells.  
Endothelial differentiation of MSCs has been achieved by several different 
methods. For example, vascular endothelial growth factor (VEGF) has been routinely 
added to culture medium [6, 118, 119] or immobilized on biomaterials [120] to promote 
endothelial differentiation in vitro. Another study reported that a combination of chemical 
(i.e., VEGF) and mechanical stimulation (i.e., shear stress) enhanced endothelial marker 
expression of MSCs [121]. Culture conditions such as serum deprivation in medium [7] 
and high cell plating density [8] induced endothelial differentiation of MSCs. 
D‘Andrea and coworkers synthesized a short VEGF-mimicking peptide, referred 
to as QK, which mimics full-length VEGF function by binding VEGF receptors [24]. 
Soluble QK promoted endothelial cell proliferation and capillary formation in vitro [24] 
and accelerated would healing in vivo [122]. The QK peptide is also bioactive when 
incorporated into biomaterials as a material-based cue, as QK-incorporated materials 
have shown enhanced endothelial cell proliferation and function [29-33]. One advantage 
of this method is that the bioactivity of the incorporated QK peptide can be retained 
longer than the bioactivity of the soluble peptide. However, none of the studies examined 
whether QK-containing materials affect endothelial differentiation of stem cells. 
To our knowledge, there have been few studies showing that engineered 
biomaterials can promote endothelial differentiation of human MSCs (hMSCs) in the 
absence of exogenous growth factors [120]. In this study, we engineered biomaterials to 
induce cell differentiation towards the endothelial lineage. The biomaterials, hereafter 
referred to as the RZ-QK protein, were manufactured by genetic engineering to include 
two different domains, a resilin structural domain (RZ) and the QK peptide domain 
(Figure 3.2.1A). We included a resilin-like sequence derived from mosquito to provide 
structural integrity, and its elastic properties [123] potentially allow us to apply our 
materials in a three-dimensional system for vascular engineering. Our previous work 






mimics VEGF function, was incorporated into the backbone of the material. The goal of 
this study was to determine if our engineered proteins could serve as microenvironments 
that enable hMSCs to survive, proliferate, and differentiate towards the endothelial 
lineage. First, we produced and characterized the protein and assessed the viability and 
metabolic activity of hMSCs on our protein. Next, we investigated whether protein-
engineered microenvironments can induce endothelial differentiation of hMSCs in the 
absence of VEGF by evaluating endothelial marker expression and function. 
 
Figure 3.2.1 The protein (RZ-QK) in this study is pure and has unstructured secondary 
structure. (A) The full amino acid sequence of the protein is shown. The protein contains 
a resilin-like sequence (RZ) and a peptide (QK) derived from VEGF. On the N-terminus, 
the protein has a T7 tag for protein identification, a heptahistidine tag (His tag) for 
protein identification or purification, and an enterokinase cleavage site for tag removal. 
(B) Protein expression and purification were confirmed by SDS-PAGE. The RZ-QK 
protein band appeared between the 17 and 23 kDa of marker proteins as the expected 
molecular weight is 18.7 kDa. The protein was successfully expressed by IPTG induction 
(lane 2) and was pure (>98.5% assessed by densitometry analysis, lane 3) after 
purification. (C) CD spectroscopy of the RZ-QK protein showed an unordered secondary 
structure. CD spectra were obtained using protein solutions at 0.2 mg/mL in Milli-Q 






3.3 Materials and Methods 
Materials and Reagents: 
All materials and reagents used in this study were purchased from Sigma-Aldrich 
unless stated otherwise. 
Material Design: 
 The recombinant DNA encoding the RZ-QK protein sequence was manufactured 
using the methods previously described [77]. In this study, the protein consisted of ten 
repeats of a resilin-like sequence (RZ) derived from Anopheles gambiae and the QK 
peptide derived from vascular endothelial growth factor (VEGF) [24]. The protein 
sequence is shown in Figure 3.2.1A. 
Protein Expression and Purification: 
 Protein expression and purification were performed as previously described [57]. 
Briefly, proteins were expressed in a 14 L fermentor (BioFlo 110, New Brunswick), and 
the expression was induced by isopropyl β-D-1-thiogalactopyranoside (IPTG, Denville 
Scientific). Following expression, proteins were purified by a combination of salting-out 
and heating methods. Briefly, undesired proteins were precipitated by adding 10% 
ammonium sulfate to the lysed cell solution, and the desired proteins were then 
precipitated by adding the same amount of ammonium sulfate as the one in the previous 
step. Thus, the final concentration of ammonium sulfate that had been added to the initial 
cell solution was 20%. Next, undesired proteins were removed by heating the sample at 
75-80 ˚C for 10 min. Protein purity was confirmed by using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis followed by densitometry 
analysis of the gel using ImageJ software (National Institutes of Health, NIH). The 
molecular weight of the protein was evaluated by matrix-assisted laser 
desorption/ionization time-of-flight (MADLI-TOF) mass spectroscopy. The composition 
of proteins was assessed by amino acid analysis (Purdue Proteomics Facility at the 






Circular Dichroism (CD): 
The secondary structure of the protein was assessed by circular dichroism. Protein 
was dissolved in Milli-Q water at 0.2 mg/mL before loading in a Jasco-815 Circular 
Dichroism spectrometer. The measurement was performed at room temperature using a 
0.1 cm path length. Three scans were averaged to show spectrum data.  
Surface Preparation and Quantification: 
Proteins were adsorbed onto surfaces, and the density of the proteins that had 
been adsorbed on tissue culture polystyrene (TCP) was assessed by the QuantiPro BCA 
assay as previously described [124]. In this study, the density of the RZ-QK protein 
ranged from 3.5 – 4.0 µg/cm2 unless stated otherwise. 
Cell Culture: 
 In all experiments, hMSCs (Lonza, PT-2501) were incubated in a humid 
environment at 37 °C with 5% CO2. For sub-culturing, cells were cultured in 
maintenance medium consisting of low-glucose Dulbecco‘s modified Eagle‘s medium 
(DMEM) supplemented with 10% fetal bovine serum (Lonza, 18-501F), 100 U/mL 
penicillin, and 100 µg/mL streptomycin (Invitrogen, 15140-122). Cells were seeded at a 
density of 5,000-6,000 cells/cm
2
 and were sub-cultured using 0.05% Trypsin-EDTA 
(Gibco, 25300-054) after they reached 60-80% confluence.  
To investigate cell responses to the protein, hMSCs were seeded on TCP or 
protein surfaces in maintenance medium at a density of 6,250 cells/cm
2 
and grown for 2 
days until they reached 70-80% confluence, at which point differentiation was initiated 
by introducing a differentiation medium. There have been several medium compositions 
reported and used for endothelial differentiation of MSCs [6, 7, 125]. We screened 
medium compositions based on literature (data not shown) and chose two different media 
as stated below.  
  To start differentiation towards the endothelial lineage, the maintenance medium 
was switched to either one of two media depending on the group. For the negative control 
(i.e., cells on TCP) and cells cultured on proteins, basal differentiation medium (BDM) 






that 10% fetal bovine serum (Lonza, 18-501F) was replaced by 5% fetal bovine serum 
(Atlanta Biologics, S11550). The positive control was differentiated on TCP in positive 
differentiation medium (PDM) consisting of endothelial cell growth medium-2 (Lonza, 
cc-3162) supplemented with an additional 50 ng/mL VEGF (R&D Systems, courtesy of 
the National Cancer Institute Preclinical Repository). The total VEGF concentration in 
PDM was 52 ng/mL. To eliminate the effect of lot-to-lot variability on cell responses, 
both media contained serum from the same lot. The medium was replaced every other 
day. All experiments were performed using cells at passage 4 to reduce the effect of cell 
senescence on differentiation, and cells were obtained from the same donor to eliminate 
donor-to-donor variability [126]. For all of the differentiation assays, the medium was 
replaced 24 h prior to the assay to prevent serum starvation.  
Live/Dead Cytotoxicity Assay: 
 Cell viability on protein surfaces was evaluated using a LIVE/DEAD kit 
(Molecular Probes, L3224). At 2 days of seeding, cells were washed with phosphate-
buffered saline (PBS) supplemented with 0.90 mM calcium chloride and 0.49 mM 
magnesium chloride (Ca/Mg-PBS). Then, cells were incubated in Ca/Mg-PBS containing 
0.5 µM calcein AM and 0.75 µM ethidium homodimer-1 for 35 min at 37°C. Cells were 
rinsed with Ca/Mg-PBS and imaged using a 4x objective on a Nikon Ti-E microscope. A 
fluorescein isothiocyanate (FITC) and a tetramethyl rhodamine isothiocyanate (TRITC) 
filter cube were used to image calcein AM and ethidium homodimer-1, respectively. Live 
and dead cells were analyzed using NIS-Elements software. To ensure that dead cells 
were detected by the dye solutions at the concentrations used, negative control cells were 
treated with 70 (v/v) % ethanol for 30 min prior to incubation with the dyes. As a positive 
control, cells were cultured on adsorbed gelatin. The gelatin surfaces were prepared by 
incubating solutions of 1 (w/v) % gelatin in Milli-Q water on each cover glass for 10 min 
at room temperature. The gelatin surfaces were dried for 30 min before cell seeding. Cell 
viability was quantified by analyzing images from each group, which had at least 250 







Cellular Metabolic Activity: 
Cellular metabolic activity was assessed by using the CytoScan WST-1 cell 
proliferation assay (G Biosciences, 786212). Briefly, the reagent was added at a ratio of 
1:10 to each well containing either BDM or PDM. Following incubation for 4 h at 37 °C, 
the absorbance of the medium was measured with a SpectraMax M2
e
 (Molecular 
Devices). At each time point, metabolic activity was determined as the percentage 
relative to the negative control for differentiation (i.e., cells on TCP differentiated in 
BDM). Five replicates per group were examined. 
Acetylated-Low Density Lipoprotein (ac-LDL) Uptake: 
At each time point, cells were trypsinized and reseeded at a density of 10,000 
cells/cm
2
 on acid-cleaned cover glasses. Cells that had been differentiated in BDM and 
PDM were reseeded in BDM and PDM without additional VEGF, respectively. After 4 h 
of seeding, cells were incubated for another 4 h in either BDM for the negative control 
and RZ-QK groups or PDM without additional VEGF for the positive control. All of the 
media contained acetylated-LDL tagged with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-
indocarbocyanine perchlorate (Dil-ac-LDL) (Alfa Aesar, BT-902) at a final concentration 
of 2 µg/mL. Then, cells were fixed with 4 (w/v) % formaldehyde in PBS and washed 
with PBS three times. Cover glasses were mounted on microscope slides and stored in the 
dark at 4 °C until imaging. 
All images were taken using a Nikon Ti-E with a differential interference contrast 
(DIC) 20x objective. The uptake of Dil-ac-LDL was imaged using a TRITC filter cube. 
Cells positive for Dil-ac-LDL uptake were chosen by setting threshold levels at which no 
fluorescence was observed in the proliferating group. The total number of cells per image 
was counted using the DIC images, and the percentage of cells positive for Dil-ac-LDL 
was determined. Five replicates per group were examined and at least 100 cells per 
replicate were counted. 
In vitro Angiogenesis Assay: 
Angiogenic response was evaluated by an in vitro angiogenesis kit (Millipore, 






was pipetted into individual wells of a 96-well plate and incubated for 2 h at 37 °C. Cells, 
which had been cultured on each surface in BDM or PDM for 12 days, were reseeded on 
the gel at 70,000 cells per well. After 6 h of incubation, cells were imaged on a Nikon Ti-
E microscope using a 4x objective. Five replicates per group were evaluated. For 
quantification, total network length per area, the number of branching points per area, and 
the number of polygons per area were evaluated using the Nikon NIS-Elements AR 
software.  
Quantitative Reverse Transcription–Polymerase Chain Reaction (qPCR): 
Samples were processed and analyzed as previously described [124] unless 
otherwise stated. The complementary DNA (cDNA) was synthesized by using at least 0.7 
µg purified RNA. For qPCR, all individual samples were run in duplicate. The primer 
sequences for vascular endothelial-cadherin (VE-cad), platelet endothelial cell adhesion 
molecule (PECAM), Ephrin-B1, Ephrin-B2, EphB4, chicken ovalbumin upstream 
promoter-transcription factor II (COUP-TFII) and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were obtained from references or designed using Primer-Blast 
on the NIH website (Table 3.8.1). Primer efficiencies were obtained by using serial 
dilutions of cDNA from either human umbilical vein endothelial cells or human aortic 
endothelial cells. During the PCR reaction, the annealing temperature was 60 ˚C except 
for Ephrin-B1 and Ephrin-B2, which had an annealing temperature of 64 ˚C. The relative 
gene expression level was calculated by the ∆∆ Ct method; GAPDH was used as the 
housekeeping gene, and expression levels were determined relative to proliferating cells 
at day 0. Three to five replicates per group were examined.  
Immunofluorescence: 
 Cells were reseeded on cover glasses as those for the ac-LDL uptake assay. After 
4 h of incubation, cells were washed with PBS twice, fixed with 4 (w/v) % formaldehyde 
in PBS at room temperature for 25 min, and washed with PBS three times. Cells were 
permeabilized with 0.1 (v/v) % Triton X-100 in PBS for 25 min and rinsed with PBS 
three times. Cells were blocked with 10 (w/v) % bovine serum albumin (BSA) in PBS for 






primary antibody specific for von Willebrand factor (vWF) (Santa Cruz Biotechnology, 
sc-53666) (diluted at a ratio of 1:50 in a 10% BSA solution) at room temperature for 1 h. 
Cells were washed with PBS three times and incubated for 1 h at room temperature with 
Alexa Fluor 488-tagged secondary antibody (Life Technologies, A11001), which was 
diluted in a 10% BSA solution at a ratio of 1:2,000. To ensure specificity of the 
secondary antibody for the primary antibody, a couple of replicates were incubated in the 
BSA solution without primary antibody and served as a no primary antibody control 
group. After washing with PBS three times, nuclei were stained for 20 min at room 
temperature with DRAQ5 (Biostatus, DR50200) diluted 1:500 in PBS. Cover glasses 
were mounted on microscope slides using a mounting medium of 50 (v/v) % glycerol in 
PBS and stored in the dark at 4 °C until imaging. 
All images were obtained on the same day with identical laser intensity and PMT 
gain settings by using a 20x objective on a Nikon Ti-EC-1 Plus microscope. Three or four 
replicates of each group were examined. A population of at least 80 cells per replicate 
was imaged. To analyze fluorescence images, Nikon NIS-Elements AR software (version 
3.2) was utilized. Individual cells were chosen as regions of interest (ROI) by setting 
threshold levels at which no fluorescence was observed in the no primary antibody 
control group. For quantification, the mean pixel intensity per cell from three replicates 
was pooled to show the percentage of the population expressing vWF.  
Statistical Analysis: 
All data are represented as mean ± standard deviation. Normality and 
homogeneity of variance were confirmed by Shapiro-Wilk and Levene‘s modified tests, 
respectively. A one-way analysis of variance (ANOVA) was performed to determine 
whether significant differences among groups existed. Statistical differences between the 
proliferating group at day 0 and an experimental group at day 12 were examined by 
Dunnett‘s test. Tukey‘s post hoc test was used to determine significant differences 
between experimental groups. All statistical analyses were conducted by using Statistical 








Material Design, Production, and Characterization: 
The full amino acid sequence of the protein is shown in Figure 3.2.1A. The RZ-
QK protein consists of a resilin domain (RZ) and QK domain (QK), which is included to 
promote endothelial differentiation of hMSCs. The recombinant DNA construct encoding 
the RZ-QK amino acid sequence was cloned as previously described [77]. The RZ-QK 
protein was successfully expressed by IPTG induction and purified, and the yield of 
purified protein was 13.8 mg per liter of culture. On an SDS-PAGE gel, the RZ-QK 
protein appeared between the 17 and 23 kDa of protein markers as the expected 
molecular weight is 18.7 kDa (Figure 3.2.1B). MALDI-TOF mass spectroscopy 
confirmed the molecular weight of the protein as the measured molecular weight was 
within 29 Da (0.15 %) of the expected molecular weight (Figure 3.8.1). The purity of the 
protein was 98.5% as assessed by densitometry analysis (Figure 3.2.1B). The 
composition of the RZ-QK protein was examined by amino acid analysis, which found 
that the each component was within 0.6 mol % of the calculated value (Table 3.8.2). CD 
spectroscopy revealed that the RZ-QK protein has an unordered structure (Figure 3.2.1C), 
which is similar to other resilin-based proteins that were previously reported [57, 124].  
Viability and Metabolic Activity of Cells on Proteins: 
 The viability and metabolic activity of hMSCs grown on the RZ-QK protein were 
evaluated by LIVE/DEAD and WST-1 assays, respectively (Figure 3.4.1). First, the 
viability of cells grown on the protein surfaces was 99.4 ± 0.3% at day 0 of 
differentiation (Figure 3.4.1A) and was statistically equivalent to that on gelatin (positive 








Figure 3.4.1 Viability and metabolic activity of human MSCs on the RZ-QK protein. (A) 
Cells were grown on gelatin (positive control surface) or on the RZ-QK surface, and cell 
viability was measured at day 0 of differentiation. Images of LIVE/DEAD assay are 
shown (top). Live cells are green, and dead cells are red. Scale bar represents 250 µm. 
Cells had a viability of 99.8 and 99.4 % on gelatin and the RZ-QK surfaces, respectively 
(bottom). One-way ANOVA determined that there was no difference in cell viability 
between the two surfaces. Data are represented as the average ± standard deviation of 
four replicates. (B) Cellular metabolic activity on the RZ-QK protein was measured by 
the WST-1 assay, and the results are presented relative to the negative control for 
differentiation (i.e., cells grown on TCP in BDM). The negative control and RZ-QK 
groups had statistically equivalent metabolic activity at two time points. The positive 
control for differentiation (i.e., cells on TCP differentiated in PDM) showed higher 
metabolic activity than the negative control and RZ-QK groups due to the presence of 
growth factors in PDM. Data are represented as the average ± standard deviation of five 
replicates. * indicates a statistical difference (p < 0.05) compared to other two groups at 






Second, cellular metabolic activity on the RZ-QK protein was measured. Before 
starting differentiation at day 0, cells on TCP and the protein were evaluated in the 
maintenance medium, and there was no difference in metabolic activity between the two 
surfaces (data not shown). For later time points at 4 and 7 days of differentiation, the two 
control groups were examined and compared to the RZ-QK group. Cells cultured on TCP 
in BDM and PDM served as negative and positive controls for differentiation, 
respectively (see details in Cell Culture of section 3.3). The cellular metabolic activity on 
the RZ-QK protein did not statistically differ from the negative control at the two time 
points (Figure 3.4.1B). The positive control cells showed higher metabolic activity than 
the negative control and RZ-QK groups. This difference is because PDM used for the 
positive control included growth factor supplements and VEGF, both of which could lead 
to increased cell proliferation, whereas BDM used for the negative control and RZ-QK 
groups did not contain any growth factors.  
RZ-QK Promoted Endothelial Function: 
The functional behavior of differentiated cells on the RZ-QK protein was 
determined after 12 days of differentiation by ac-LDL uptake (Figure 3.4.2) and in vitro 
angiogenesis assays (Figure 3.4.3), respectively. First, the percentage of cells positive for 
internalized ac-LDL was quantified (Figure 3.4.2B). For the proliferating group at day 0, 
only 2.8% of cells internalized ac-LDL. In contrast, after 12 days, the percentage of cells 
positive for ac-LDL was 37.2% on the RZ-QK protein and 66.1% for the positive control. 
The ac-LDL internalization by cells on the RZ-QK protein was statistically higher than 
that of the proliferating group at day 0 and the negative control at day 12 (21.5%).  
The ability to form networks was determined by reseeding differentiated cells on 
ECMatrix after 12 days of differentiation (Figure 3.4.3). Cells differentiated on RZ-QK 
showed significantly higher total network length, number of branching points, and 
number of polygons compared to negative control cells. Of particular note, the three 
variables examined for network formation of cells grown on RZ-QK were statistically 







Figure 3.4.2 Internalization of acetylated low density lipoprotein (ac-LDL) by cells 
differentiated on the RZ-QK protein. Cells were grown on each surface for 12 days. (A) 
Fluorescence imaging of cells positive for ac-LDL (white) are shown. Scale bar 
represents 100 µm. (B) The percentage of cells positive for ac-LDL was calculated. At 
day 12, cells on the RZ-QK protein showed statistically higher ac-LDL internalization 
than proliferating cells (day 0) and negative control cells at day 12 and lower 
internalization than positive control cells at day 12. Data are represented as the average ± 
standard deviation of five replicates. Letters indicate statistically different Tukey groups. 
* represents a statistical difference compared to proliferating group at day 0 (p < 0.05) as 








Figure 3.4.3 Network formation by cells grown on the RZ-QK protein. Cells were 
trypsinized and seeded on ECMatrix after 12 days of differentiation. (A) Phase contrast 
images of cells on ECMatrix after 6 h of incubation. Scale bar represents 250 µm. (B) 
Network formation in each group was quantified. Cells grown on the RZ-QK protein 
exhibited substantially higher total network length, number of branching points, and 
number of polygons compared to negative control cells. These variables for cells on the 
RZ-QK protein were statistically equivalent to those of positive control cells. Data are 
represented as the average ± standard deviation of five replicates. Letters indicate 






Endothelial Marker Expression on RZ-QK: 
Endothelial-specific gene expression levels were analyzed by qPCR after 4 days 
of differentiation. First, two endothelial-specific markers, VE-cad and PECAM, were 
evaluated. Gene expression levels of VE-cad for cells on the RZ-QK protein were 
markedly enhanced compared to all groups. The RZ-QK protein induced a 7.7-fold and 
1.8-fold increase in VE-cad gene expression compared to the proliferating group at day 0 
and negative control at day 4, respectively (Figure 3.4.4A). For the expression level of 
PECAM, there was no difference between cells on the RZ-QK protein and negative 
control cells (Figure 3.4.4B). For both genes, the expression levels in negative control 
cells were higher than those in positive control cells. We also examined gene expression 
levels of two other endothelial-specific markers, vWF and VEGF R2, at day 4. However, 
those gene expression levels could not be reliably detected as measured levels were very 
low (data not shown).  
 
Figure 3.4.4 Expression levels of endothelial genes. The gene expressions were measured 
by qPCR after 4 days of differentiation. Endothelial gene expression levels for (A) VE-
cad, (B) PECAM, (C) Ephrin-B1 were analyzed, normalized by GAPDH, and are shown 
relative to the proliferating group at day 0. The gene expression levels of VE-cad and 
Ephrin-B1 in cells differentiated on RZ-QK for 4 days were statistically higher than those 
of the proliferating (day 0) and negative control groups. Data are represented as the 
average ± standard deviation of three to five replicates. Letters indicate statistically 
different Tukey groups. * represents a statistical difference compared to the proliferating 
group at day 0 (p < 0.05) as assessed by Dunnett‘s test. 
In addition, the expression level of Ephrin-B1, which is a marker expressed in 






in cells on the RZ-QK protein compared to proliferating cells at day 0 and negative 
control cells at day 4, respectively (Figure 3.4.4C). The positive control cells showed a 
statistically higher expression level of Ephrin-B1 compared to cells on the RZ-QK 
protein. Arterial-specific and venous-specific markers were also examined, but there were 
no differences in expression levels of Ephrin-B2 (arterial), EphB4 (venous), or COUP-
TFII (venous) between cells on the RZ-QK protein and negative control cells (Figure 
3.8.2A-C).  
  The expression of vWF by cells on RZ-QK was assessed at 12 days of 
differentiation by immunofluorescence (Figure 3.4.5). The protein expression was 
analyzed by evaluating the mean pixel intensity per cell and the intensities of three 
replicates were pooled to show the percentage of the population expressing vWF. The 
intensity histograms of RZ-QK and positive control groups at day 12 shifted from those 
of the proliferating group at day 0 and the negative control at day 12 (Figure 3.4.5B). At 
the mean intensity per cell above 130, the percentage of cells expressing vWF was 0.9% 
for the proliferating group at day 0 and 3.8% for negative control. In contrast, 29.6% of 








Figure 3.4.5 Immunostaining for von Willebrand factor (vWF). The protein expression 
for vWF was evaluated at day 0 (proliferating) and day 12 of differentiation. (A) 
Fluorescence images show vWF expression (green) and nucleus (red). Scale bar 
represents 250 µm. (B) The percentage of cells expressing vWF in each group was 
determined. The mean pixel intensity per cell from three replicates was pooled (n > 300 
per group) to assess the percentage of population expressing vWF. The intensity 
histograms of RZ-QK and positive control groups at day 12 shifted from those of the 
proliferating group at day 0 and negative control at day 12. At the mean intensity per cell 
above 130, the percentage of cells expressing vWF was 0.9% for the proliferating group 
at day 0 and 3.8% for negative control. In contrast, 29.6% of cells on RZ-QK and 37.9% 
of cells in the positive control expressed vWF. 
 
Finally, after 12 days of differentiation, VEGF R2 marker expression was 
analyzed by Western blot (Figure 3.8.2D). All groups at day 12 showed higher VEGF R2 
protein expression than proliferating cells at day 0, but there was no difference in marker 
expression between cells on the RZ-QK protein and negative control cells. 
Protein Specificity on Endothelial Differentiation: 
We investigated whether the increased endothelial function of cells differentiated 
on the RZ-QK protein is protein-specific. To do so, cells were cultured on non-interactive 
bovine serum albumin (BSA) with a surface density of 2.53 ± 0.8 µg/cm
2
 (statistically 
equivalent to RZ-QK density). On these BSA surfaces, cell viability and metabolic 
activity was not adversely affected (Figure 3.8.3A – B), but cell differentiation was not 
enhanced compared to the negative control. Specifically, at 12 days of differentiation, 






to that of negative control cells and lower than cells on the RZ-QK protein (Figure 
3.4.6A). In addition, cells grown on BSA surfaces remained rounded on ECMatrix and 
did not form extensive networks (data not shown). The quantified variables of network 
formation for cells grown on BSA surfaces were statistically similar to those of negative 
control cells (Figure 3.4.6B). Thus, these data indicate that the composition of RZ-QK, 
and not the mere presence of protein, actively promoted endothelial function. 
To investigate whether the authentic QK peptide sequence can induce endothelial 
differentiation in a sequence-specific manner, we examined cell responses on a negative 
control protein, RZ-scQK. The RZ-scQK protein has the same amino acid composition as 
the RZ-QK protein does, but the order of amino acids in the QK domain has been 
scrambled (Figure 3.8.4A). The RZ-scQK protein was produced and analyzed by the 
same methods as the RZ-QK protein (Figure 3.8.4B – C). The density of RZ-scQK, 3.46 
± 0.8 µg/cm
2
, was statistically equivalent to that of RZ-QK. The differentiation results 
show that ac-LDL internalization by cells on the RZ-scQK protein did not statistically 
differ from that of negative control cells nor from that of cells on the RZ-QK protein 
(Figure 3.4.6C). Gene expression levels on the RZ-scQK protein were measured, but 
there were no differences in gene expression levels between cells on RZ-QK and RZ-







Figure 3.4.6 Examination of specificity of the RZ-QK protein or the QK domain on 
endothelial differentiation. Cell differentiation on non-interactive BSA surfaces or the 
RZ-scQK protein (i.e., a   negative control protein containing scrambled sequence in the 
QK domain) was compared to those on the RZ-QK protein. The density of each surface 
was statistically equivalent to that of the RZ-QK surface. (A) The percentage of cells 
positive for ac-LDL on BSA surfaces was statistically lower than that on the RZ-QK 
protein at 12 days of differentiation. (B) After 12 days of culture, the total network length 
and the number of branching points per area on BSA surfaces were statistically 
equivalent to those of the negative control and lower than those on the RZ-QK protein. 
The number of polygons is not shown because there was no polygon formation by cells 
cultured on BSA surfaces. Negative control and RZ-QK data is from the same experiment 
as shown in Figure 3.4.3B. (C) At 12 days of differentiation, the internalization of ac-
LDL by cells on the RZ-scQK protein did not statistically differ from that of negative 
control cells nor from that of cells on the RZ-QK protein. Negative control and RZ-QK 
data is from the same experiment as shown in Figure 3.4.2B. Data are represented as the 
average ± standard deviation of five replicates. Letters indicate statistically different 
Tukey groups. * represents a statistical difference compared to proliferating group at day 















Endothelial differentiation of stem cells has been previously achieved using 
different culture conditions. For example, mesenchymal stem cells can be differentiated 
into endothelial-like cells by serum deprivation [7], shear stimulation [121], or high 
seeding density [8]. The most common method is to use growth factors such as VEGF in 
low serum conditions. Exogenous VEGF at 50-100 ng/mL increased endothelial–specific 
markers including vWF and VE-cad and enhanced endothelial functional behaviors such 
as ac-LDL uptake and network formation by cells after 7-14 days of differentiation 
compared to proliferating (i.e., undifferentiated) cells [6, 118, 119, 128]. These studies 
have focused on promoting differentiation by using growth factors. In contrast, it has 
been suggested that endothelial differentiation can be induced by using biomaterials. One 
study reported that endothelial differentiation of rat MSCs can be induced by a 
synergistic effect of matrix stiffness and VEGF [40]. Another study demonstrated that 
VEGF-functionalized titanium promoted endothelial differentiation of hMSCs in the 
absence of growth factors [120]. However, there are not many studies examining the 
effect of engineered materials on endothelial differentiation of stem cells. 
This study illustrates an alternative strategy to promote endothelial differentiation 
by utilizing protein-engineered microenvironments without exogenous VEGF. Our 
material-based approach has several advantages compared to utilizing soluble growth 
factors. Soluble VEGF is routinely used at a concentration of 50 ng/mL [6, 118, 119, 
125]. This supra-physiological concentration is approximately 1000 times higher than the 
measured concentration of free VEGF in healthy tissues [129]. An excessive amount of 
VEGF may lead to vascular leakage and hypotension [130]. However, our protein-based 
microenvironments reduce the need for supra-physiological concentrations of growth 
factors. In addition, the bioactivity of the material could be retained throughout cell 
differentiation. In contrast, soluble VEGF is not effective for long time periods due to its 
short half-life (< 30 min) [131], and it may need to be added until the desired 
differentiation state is achieved. Thus, the use of our proteins could be more cost-
effective to promote endothelial differentiation. Third, soluble VEGF could be diffused 






microenvironments could be retained at the target sites and enable homogeneous 
differentiation.  
Our results showed that even in the absence of VEGF, protein-based 
microenvironments supported hMSC growth and promoted endothelial differentiation of 
cells. First, we confirmed that the RZ-QK protein was cytocompatible and supported 
normal metabolic activity of hMSCs (Figure 3.4.1). In differentiation studies, we 
observed that, in the absence of VEGF, the RZ-QK protein elicited enhanced endothelial 
differentiation compared to the negative control group (Figure 3.4.2, Figure 3.4.3, Figure 
3.4.4, and Figure 3.4.5). We demonstrated that endothelial function such as uptake of ac-
LDL (Figure 3.4.2) and network formation (Figure 3.4.3) and expression levels of 
endothelial genes (Figure 3.4.4A and C) were increased for cells cultured on our protein 
for 12 days compared to those of negative control cells. In addition, we observed that ~30% 
of cells on the RZ-QK protein expressed vWF marker at 12 days of differentiation, 
whereas ~4% of negative control cells expressed vWF (Figure 3.4.5).  
Of particular note, network formation of cells on the RZ-QK protein was as robust 
as that of positive control cells. For example, the variables used to quantify network 
formation were statistically equivalent for cells on the RZ-QK protein and positive 
control cells (Figure 3.4.3). Previous studies showed that the same type of medium (i.e., 
PDM) used in our positive control enhanced network formation [6, 118, 119, 128]. Thus, 
our result implies that the RZ-QK protein alone had the same effect on promoting 
network formation as growth factors, including VEGF, that were used in PDM. In 
contrast, the uptake of ac-LDL of cells on the RZ-QK protein was not statistically 
equivalent to that of positive control cells. It could be possible to further enhance the cell 
responses on the RZ-QK protein through shear stress [121], co-culture with endothelial 
cells under hypoxic conditions [132], or mechanical cues [40]. 
As presented in Figure 3.4.4, we observed an increase in gene expression levels of 
VE-cad on the RZ-QK protein at 4 days of differentiation compared to proliferating and 
negative control groups. However, there was no significant difference in PECAM gene 
expression between the RZ-QK and negative control groups. Unexpectedly, our positive 






Compared to negative and RZ-QK protein groups, positive control cells exhibited 
statistically lower gene expression levels of VE-cad and PECAM. One potential reason 
for low expression of VE-cad and PECAM in the positive control is that 4 days of 
differentiation that we selected may not be right time point to capture upregulation of 
these two genes of positive control cells. There were not available literatures 
demonstrating time-course expression levels of two genes of cells that had been 
endothelially differentiated from adult stem cells. However, other aspects of our positive 
control cells such as functional behaviors (Figure 3.4.2 and Figure 3.4.3) and protein 
expression (Figure 3.4.5) supported that cells in positive control had been differentiated 
towards endothelial lineage at later time point than day 4. 
We also investigated whether cells undergo arterial or venous endothelial 
differentiation by examining several marker genes. Ephrin-B1, a marker expressed both 
in arteries and veins [127], was markedly upregulated in cells on the RZ-QK protein 
compared to proliferating and negative control cells (Figure 3.4.4C). Previous studies 
demonstrated that Ephrin-B1 is correlated with angiogenic responses as it promoted 
proliferation and migration of human endothelial cells in vitro, vessel formation in 
tumors [133], and network formation of endothelial cells on Matrigel [134]. Our results 
were consistent with these previous observations since the RZ-QK protein enhanced both 
Ephrin-B1 gene expression and network formation on ECMatrix.  
Next, we evaluated arterial-specific (Ephrin-B2) and venous-specific (EphB4 and 
COUP-TFII) genes. There are not many studies that examine the molecular mechanism 
of arterial and venous specification from stem cells; however, VEGF and Notch signaling 
defines arterial specification by increasing Ephrin-B2 expression [135], whereas COUP-
TFII maintains vein identity and is required for EphB4 expression [136, 137]. Our results 
show that there is no significant difference in arterial or venous gene expression levels 
between cells on the RZ-QK protein and negative control cells (Figure S2A-C). However, 
we observed that different medium compositions resulted in different patterns in gene 
expression levels. BDM without growth factors elicited an increase in venous gene 
expression (e.g., EphB4 and COUP-TFII) in the negative control and RZ-QK groups 






showed that PDM containing VEGF at a total concentration of 52 ng/mL promoted 
higher arterial expression (e.g., Ephrin-B2) in positive control cells compared to 
proliferating cells. Interestingly, PDM also increased the gene expression of COUP-TFII, 
which is a venous marker, in the positive control compared to the proliferating group. 
Thus, we postulate that cells differentiated in PDM exhibit a mixed phenotype. Arterial 
specification is activated from a default venous state by VEGF and Notch signaling [137]. 
Because we measured gene expression levels at a very early time point (day 4), it is 
possible that positive control cells in PDM had just started arterial specification and 
therefore exhibited a mixed phenotype.  
To ensure that enhanced endothelial differentiation can be attributed to our RZ-
QK protein specifically, we investigated cell differentiation on two control protein 
surfaces, BSA and RZ-scQK protein surfaces. We demonstrated that there was no 
increase in the uptake of ac-LDL and network formation by cells on non-interactive BSA 
surfaces compared to negative control cells (Figure 3.4.6A – B). However, each of those 
two responses by cells on BSA surfaces was statistically lower than that on RZ-QK 
surfaces at the same protein density (Figure 3.4.6A – B). Thus, the mere presence of 
protein on surfaces was insufficient to promote endothelial differentiation of hMSCs, and 
the specific composition of the RZ-QK protein appeared to be necessary for promoting 
differentiation. Next, the RZ-scQK protein was used to examine the specific role of the 
QK peptide on cell differentiation. At the same protein density, there was no significant 
difference in internalization of ac-LDL and gene expression levels between cells on RZ-
QK and RZ-scQK proteins (Figure 3.4.6C and Figure 3.8.4D). However, because cells on 
the RZ-scQK protein showed statistically equivalent ac-LDL uptake to negative control 
cells but those on the RZ-QK protein did not, endothelial function on the RZ-scQK 
protein may be at an intermediate stage between that of negative control cells and cells on 
the RZ-QK protein. This intermediate cell response may be caused by non-specific 
interactions with the amino acids in the RZ-scQK protein.  
In this study, we demonstrated that protein-engineered microenvironments can 






We envision that our proteins can be potentially used to create endothelial cells for use in 
vascular grafts for successful vessel reconstruction.  
3.6 Conclusions 
This work demonstrates an alternative strategy to obtain endothelial cells by using 
protein-based microenvironments. We demonstrated that endothelial differentiation of 
hMSCs can be induced by our protein-engineered microenvironments in the absence of 
exogenous VEGF. First, we showed that the protein was cytocompatible and supported 
metabolic activity of cells. Next, we showed that the protein promoted endothelial-
specific gene and protein markers and endothelial function. The enhanced cell 
differentiation on the RZ-QK protein is protein-specific. Thus, our protein is a promising 
tool to obtain endothelial cells for use in vascular grafts.  
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3.8 Supporting Information 
Western Blot Analysis: 
 Cells were rinsed with PBS twice and treated with radio immunoprecipitation 
assay (RIPA) buffer containing protease and phosphatase inhibitor cocktails and 
phenylmethylsulfonyl fluoride (PMSF). Collected cells were frozen at -20 °C before 
being assayed. Frozen cells were thawed, vortexed, and centrifuged to remove cell debris, 
and the supernatant was collected. To measure the total protein concentration of each 
sample, the QuantiPro BCA assay kit was utilized. Briefly, 25 µL of cell lysate was 
incubated with an equal amount of the reagent for 1 h at 60 °C, and the absorbance at 562 
nm was measured. A standard curve was created using a BSA solution in RIPA buffer to 
determine the total protein amount of each sample.  
 A total of 50 µg of proteins were loaded on a 10% SDS-PAGE gel, and the gel 
was run at 125 V for 1.5 h. The proteins were transferred to a nitrocellulose membrane at 
55 V for 10 h at 4 °C. The membrane was blocked with 5 (w/v) % dry milk in Tris-
buffered saline with Tween-20 (TBST) buffer at 4 °C overnight. The membrane was 
incubated with primary antibody (Santa Cruz Biotechnology) in blocking solution for 1.5 
h at room temperature and then incubated with horseradish peroxidase (HRP)-tagged 
secondary antibody (Santa Cruz Biotechnology, sc-2005) in blocking solution for 1 h at 
room temperature. Details concerning the antibodies used in this study are shown inTable 
3.8.3. Proteins were detected with a chemiluminescent substrate (Pierce, 32132). The 
intensity of the desired band was quantified by ImageJ analysis software (NIH) and 
normalized by that of β-actin. The data are shown as the pixel intensity relative to the 










Primer sequence (5‘ → 3‘) Efficiency Product length (bp) Reference 
VE-cad NM001795.3 FW CCAGGACGCTTTC
ACCATTGAGACA 
92% 71 [138] 
RV CCAGAGGCTTCAT
GGGCTTGATGATG 
PECAM NM000442.3 FW TCTATGACCTCGC
CCTCCACAAA 




Ephrin-B1 NM004429.4 FW GTTCTCGACCCCA
ACGTGTT 
100% 153 [22] 
RV CAGGCTTCCATTG
GATGTTGA 
Ephrin-B2 NM004093.3 FW CTCCTCAACTGTG
CCAAACCA 
96% 151 [22] 
RV GGTTATCCAGGCC
CTCCAAA 
EphB4 NM004444.4 FW CAGCTTTGGAAGA
GACCCTGC 
107% 77 Designed 
RV GTCCACCTGAGGG
AATGTACA 
COUP-TFII NM021005.3 FW CTAGGTGGTGATC
TGCCCTC 
98% 71 Designed 
RV GGAAAGAGTCAAC
TCGCCG 
GAPDH NM002046.3 FW ACAGTCAGCCGCA
TCTTCTT 









Table 3.8.2 Amino acid analysis of the RZ-QK protein. 
 
Table 3.8.3 Antibodies used for Western blot analysis. 




VEGF receptor 2  
(VEGF R2) 
sc-6251 1:100 1:1000 
β-actin sc-47778 1:200 1:2000 
























Figure 3.8.1 MALDI-TOF mass spectroscopy of the RZ-QK protein. The measured 
molecular weight of RZ-QK (18740 Da) was within 29 Da (0.15 %) of the expected 







Figure 3.8.2 Expression levels of endothelial markers. Gene and protein expression levels 
were measured by (A-C) qPCR after 4 days of differentiation and (D) Western blot 
analysis after 12 days of differentiation. Arterial and venous gene expression levels for 
(A) Ephrin-B2 (arterial), (B) EphB4 (venous), and (C) COUP-TFII (venous) were 
normalized by GAPDH levels and are shown relative to the proliferating group at day 0. 
(D) VEGF R2 protein expression was examined and shown relative to the proliferating 
group (day 0). Data are represented as the average ± standard deviation of three to five 
replicates. Letters indicate statistically different Tukey groups. * represents a statistical 
difference compared to the proliferating group at day 0 (p < 0.05) as assessed by 







Figure 3.8.3 Cell viability and metabolic activity on BSA surfaces. (A) Cell viability on 
BSA surfaces (99.5%) was statistically equivalent to that on gelatin surfaces (99.8%) 
(left). The cell viability data on gelatin surfaces is from the same experiment as shown in 
Figure 3.4.1A. An image of the LIVE/DEAD assay for cells grown on BSA surfaces is 
shown (right). Scale bar represents 250 µm. (B) There was no difference in metabolic 
activity, as confirmed by one-way ANOVA, between cells on BSA surfaces and negative 
control cells at two time points. The negative control data is from the same experiment as 
shown in Figure 3.4.1B. Data are represented as the average ± standard deviation of (A) 







Figure 3.8.4 Examination of specificity of the QK domain on cell differentiation. (A-C) 
The RZ-scQK protein was manufactured and analyzed and (D) gene expression levels of 
cells on the RZ-scQK protein were measured. (A) The full amino acid sequence of the 
RZ-scQK protein is shown. (B) The purity of the protein was confirmed by SDS-PAGE 
gel. The RZ-scQK protein appeared at the expected molecular weight of 18.7 kDa. The 
purity was 96.1% as determined by densitometry analysis. (C) MALDI-TOF mass 
spectroscopy of the RZ-scQK protein. The measured molecular weight of RZ-QK (18763 
Da) was within 52 Da (0.27 %) of the expected molecular weight (18711 Da). (D) 
Endothelial gene expression levels of cells cultured on the RZ-scQK protein for 4 days 
were assessed by qPCR. For all markers, there was no statistical difference in expression 
levels between cells on RZ-QK and RZ-scQK proteins as evaluated by a one-way 
ANOVA. The RZ-QK data are from the same experiments shown in Figure 3.4.4A-C and 







CHAPTER 4. ENZYMATICALLY CROSSLINKED PROTEIN MATRICES WITH 
TUNABLE STIFFNESS FOR ENDOTHELIAL DIFFERENTIATION OF STEM 
CELLS 
This chapter consists of a manuscript by Kim Y, Gill EE, and Liu JC, prepared for 
submission in 2014. 
4.1 Abstract 
The stiffness of cellular microenvironments has recently received significant 
attention. While conventional culture substrates used for endothelial differentiation have 
stiffness much higher compared to that of sub-endothelial environments, there have been 
few studies examining the effect of matrix stiffness on endothelial differentiation of stem 
cells. Thus, the goal of this study was to create relatively soft matrices compared to the 
conventional substrates and to evaluate whether human mesenchymal stem cells (hMSCs) 
can be differentiated into endothelial-like cells by matrix stiffness. We used tissue 
transglutaminase to create protein matrices varying stiffness. We observed that matrix 
stiffness modulated spreading and endothelial differentiation of cells, as the stiffest 
matrices increased cell spreading and endothelial differentiation compared to the softest 
matrices. In addition, endothelial differentiation on our matrices was statistically 
equivalent to that on hard glass surface. Thus, our tunable matrix system is a promising 
tool to obtain endothelial-like cells and to provide more native sub-endothelial 








In native tissue, cells are surrounded by extracellular matrix containing many 
types of microenvironmental cues that affect cell behavior. Microenvironmental cues 
consist of biochemical cues (e.g., growth factors and ligands), biophysical cues (e.g., 
stiffness, topography, and shear stress and strain), extracellular matrix proteins (e.g., 
collagen and laminin), and cell-to-cell interaction (e.g., Notch signaling and cadherins) 
[20]. These cues interplay with each other in a spatial and temporal manner, thereby 
regulating cell behavior. 
Among the cues, the stiffness of microenvironment has recently received 
significant attention. Many researchers have used cell culture substrate such as glass and 
plastic surfaces for in vitro experiments. However, some native tissue environments are 
much softer than these hard surfaces. For example, brain and muscle have an elastic 
modulus of several hundred Pa and ~12 kPa [140], respectively, whereas tissue culture 
plastic or glass surfaces has an elastic modulus of several GPa. This stiffness difference 
between cell culture substrate and native tissue may hinder successful translation of in 
vitro system to in vivo application. Thus, when designing engineered tissue environments 
by using biomaterials, the material stiffness is considered as an important parameter. 
There have been many studies demonstrating how the stiffness of two-
dimensional matrices affects cell behavior. The matrix stiffness can be controlled by the 
density of crosslinked networks in the matrix, which is often varied by material and 
crosslinker concentrations [54, 141]. Rowlands et al. demonstrated that cell spreading 
was dependent upon matrix stiffness as stiffer matrices promoted greater cell spreading 
than softer ones [142]. A number of studies have shown that matrix stiffness can specify 
stem cell fate towards different lineages such as brain, muscle, and bone [34, 142]. 
Endothelial cells present on the inner surface of blood vessels and regulate 
homeostasis, blood coagulation, and thrombosis [143]. Endothelial cells reside on soft 
sub-endothelial matrices that have an indentation modulus of ~3 kPa [144] and show 
different behaviors such as migration and vessel formation, depending on matrix stiffness 
[145, 146]. For vascular tissue engineering applications, autologous endothelial cells are 







endothelial cells show dysfunction due to vascular diseases [114], bone marrow 
mesenchymal stem cells (MSCs) can serve as an alternative cell source for vascular tissue 
construction because of their proliferation capacity and endothelial differentiation 
potential. Biochemical cues such as vascular endothelial growth factor (VEGF) have been 
used to promote endothelial differentiation of MSCs [6, 120]. However, there have been 
few studies showing whether matrix stiffness can induce endothelial differentiation of 
stem cells [147].  
The goal of this study was to produce crosslinked matrices with varying stiffness 
and to evaluate whether endothelial-like cells can be obtained by differentiating stem 
cells on the matrices. The crosslinker used in this study is the enzyme transglutaminase, 
which is found in a variety of tissues [42]. The transglutaminase-mediated crosslinking is 
mild and biocompatible, as previous reports demonstrated that cells seeded on matrices or 
encapsulated in hydrogels crosslinked with transglutaminase were viable and did not lose 
proliferation capacity [148, 149]. We created protein matrices by crosslinking with 
transglutaminase and varied matrix stiffness by changing total protein concentration. We 
characterized material properties such as matrix stiffness, swelling ratio, and water 
content. Finally, we examined cell viability and proliferation on the matrices and 
evaluated how matrix stiffness influences spreading and endothelial differentiation of 
human MSCs (hMSCs). 
4.3 Materials and Methods 
Materials and Reagents: 
All materials and reagents were purchased from Sigma-Aldrich unless otherwise 
stated.  
Protein Production: 
 Proteins used in this study were designed and produced as previously described 
[57]. Briefly, proteins were expressed by inducing with 2.5 mM of isopropyl β-D-1-
thiogalactopyranoside (IPTG, Denville Scientific) in a fermentor (BioFlo 110, 14 L 







salting-out and heating methods. The desired proteins were precipitated by adding total 
20% ammonium sulfate to lysed cell solution, and undesired proteins were removed by 
heating at 75-80 °C for 10 min. Protein purity was evaluated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis followed by densitometry 
analysis of the gel using ImageJ software (National Institutes of Health, NIH).  
Preparation of Crosslinking Mixture: 
For transglutaminase-mediated crosslinking, two buffers were prepared as 
previously described [150]. The proteins were dissolved at desired concentrations in ice-
cold buffer containing 50 mM Tris-HCl (pH 8.0), 10 mM CaCl2, and 1 mM 
ethylenediaminetetraacetic acid (EDTA). The transglutaminase was dissolved at 4 
unit/mL (U/mL) in ice-cold buffer of Tris-HCl (pH 8.0), 10 mM dithiothreitol (DTT), and 
1 mM EDTA. An equal amount of the protein and enzyme solutions was mixed, and the 
mixture was centrifuged briefly to remove air bubbles before incubation at 37 °C. 
For chemical crosslinking, tris(hydroxylmethyl)phosphine (THP, Strem 
Chemicals) was used. The proteins were dissolved in phosphate-buffered saline (PBS) 
and mixed with ice-cold THP in PBS. The molar crosslinking ratio of primary amines in 
the proteins to hydroxymethyl phosphine groups in THP was 1:5. The mixture was 
centrifuged to remove air bubbles before crosslinking at 37 °C.  
Contact Angle Measurement: 
 The crosslinking mixture was prepared as described in previous section. 48 µL of 
the mixture were added to 16-mm-diameter, 250-µm-thick silicone mold (McMaster Carr, 
87315K62) on an 18-mm cover glass. Another silicone sheet at a thickness of 500 µm 
(McMaster Carr, 87315K61) was placed on top of the mold. After incubation for 1.5 h at 
37 °C in a humid environment, crosslinked protein matrices were cooled to room 
temperature overnight in a humid environment and the molds were removed. For contact 
angle measurement, excess water was removed by a micropipette, and spreading of PBS 
on the matrices was monitored for 1 min by using a Pinnacle studio 8 ATI version. The 









 Matrix modulus was measured on an AR2000 rheometer (TA Instrument) by 
using a 15 mm plate-on-plate geometry. The chilled mixture of proteins and enzyme was 
prepared as described in preparation of crosslinking mixture of section 4.3, briefly 
centrifuged, and immediately placed onto the bottom plate at 4 °C. The top plate was 
lowered and set at a gap distance of 825 µm with a slow rotation to ensure that the 
mixture homogeneously contacted the top plate. To prevent gel dehydration during 
measurements, mineral oil was used to cover the exposed edge of the mixture. After 
increasing the plate temperature to 37 °C, rheological measurements were performed at 
that temperature for 1 h. Frequency and strain sweeps were performed at a range of 0.1-
10 rad/s and 0.1-10%, respectively, to determine linear viscoelastic region. Time sweep 
was conducted at 1 rad/s of angular frequency and 1% strain. Three replicates per group 
were measured.  
Swelling Ratio and Water Content Measurements: 
The chilled mixture of proteins and enzyme was prepared as described in 
preparation of crosslinking mixture of section 4.3, and 20 µL of the mixture was loaded 
to 6.5-mm-diameter, 500-µm-thick silicone mold attached on 12-mm-diameter cover 
glass. The silicone cover was then placed onto the top of the mold. The constructs were 
placed in a humidified incubator at 37 °C for 1 h to allow cross-linking to take place. 
After cooling down matrices at room temperature, the molds were removed and the 
matrices on cover glasses were incubated in 5 mL PBS at 37 °C. 
The whole constructs (i.e., matrices on cover glasses) were weighed at 3 days of 
swelling. The excess PBS on the bottom of the cover glass and on the matrix was 
removed with a Kimwipe and a micropipette, respectively. The weight of swollen matrix 
(Ws) was obtained by subtracting the weight of cover glass that had measured before 
matrix fabrication from the weight of swollen matrix on the cover glass. The constructs 
were rinsed with Milli-Q water, frozen at -80 °C, and lyophilized. The weight of dry 
matrix (Wd) was calculated by subtracting the weight of cover glass from the weight of 







using equations of Ws/ Wd and 100 * (Ws-Wd) / Ws, respectively. Four to five replicates 
per group were examined.  
Preparation of the RZ-TGase Matrices for Cell Culture: 
 The mixture of proteins and enzyme was prepared as described in preparation of 
crosslinking mixture of section 4.3. 10.5 µL of the mixture were added to 8-mm-diameter, 
250-µm-thick silicone mold on a 12-mm cover glass. Another silicone sheet at a 
thickness of 500 µm was placed on top of the mold. After incubation for 1.5 h at 37 °C in 
a humid environment, crosslinked protein matrices were cooled to room temperature 
overnight in a humid environment. The next day, the molds were gently removed, and a 
cloning cylinder (Corning, 3166-10) was placed on each cover glass on which the matrix 
had been made. To prevent medium leakage from the cloning cylinder during cell culture, 
sterile vacuum greases were applied on the bottom of the cylinder. The whole matrix 
system was placed into a well of tissue culture polystyrene (TCP). The matrices were 
sterilized with 70 (v/v) % ethanol at room temperature for 30 min and rinsed with PBS 
for 4 h with several exchanges. Finally, the matrices were incubated overnight at 37 °C 
with 5% CO2 in serum-free endothelial basal medium (Lonza, CC-3162) before cell 
seeding. 
Cell Culture: 
hMSCs (Lonza, PT-2501) were cultured at 37 °C with 5% CO2 in a humid 
environment. Cells were grown in maintenance medium containing low-glucose DMEM, 
10% fetal bovine serum (Lonza, 18-501F), 100 U/mL penicillin, and 100 µg/mL 
streptomycin (Invitrogen, 15140-122). For endothelial differentiation, cells were seeded 
on cover glasses or protein matrices at a density of 7000 cells/cm
2
 in the differentiation 
medium consisting of endothelial growth medium-2 (Lonza, CC-3162) and additional 50 
ng/mL VEGF (R&D Systems, courtesy of the National Cancer Institute Preclinical 
Repository). The total VEGF concentration in the differentiation medium was 52 ng/mL. 
To avoid the effect of serum variability on cell responses, the differentiation medium 







same lot. Cells at passage 4 were used in all experiments. The medium was replaced 
every two days. 
Live/Dead Cytotoxicity Assay: 
 The viability of cells on protein matrices was assessed by a LIVE/DEAD kit 
(Molecular Probes, L3224). At desired time point, cells on cover glasses or matrices were 
incubated in the differentiation medium containing 0.5 µM calcein AM and 0.75 µM 
ethidium homodimer-1 (EthD-1) for 40 min at 37 °C. Cells were rinsed with PBS 
containing 0.90 mM CaCl2 and 0.49 mM MgCl2, and cells on all surfaces were imaged on 
a Nikon Ti-E microscope. Cells on cover glasses that had treated with 70 (v/v) % ethanol 
for 30 min served as a control for dead cells. Cell viability was assessed by analyzing live 
and dead cells using Nikon NIS-Elements AR software (version 3.2). Three to four 
replicates per each group were examined and at least 200 cells per replicate were 
examined. 
Cell Proliferation: 
 Cell proliferation was evaluated by CytoScan WST-1 (G-Biosciences, 786212) 
and BrdU (Millipore, QIA58) cell proliferation assays. First, cellular metabolic activity 
was measured by WST-1 assay. At 1 day after seeding, the reagent was added to medium 
at a ratio of 1:10 and incubated for 4 h at 37 °C. The medium were transferred to new 
plate and the absorbance was measured by using a SpectraMax M2
e
 (Molecular Devices). 
Cellular metabolic activity was determined as the percentage relative to cells on glass 
surface. Five to six replicates per group were examined. 
Second, after 2 days of seeding, cells were incubated in the differentiation 
medium containing BrdU for 24 h and then fixed with 4 (w/v) % formaldehyde in PBS 
for 25 min. Cells were rinsed with PBS twice and incubated in 2N HCl for 30 min to 
denature DNA. Cells were treated with PBS containing 1 (w/v) % bovine serum albumin 
(BSA) and 0.1 (v/v) % triton X-100 for 1 h. Then, cells were incubated for 1 h with anti-
BrdU antibody, which was diluted in dilution buffer at a ratio of 1:100. Following rinsing 
with PBS twice, cells were incubated for 1 h with Alexa Fluor 488-tagged secondary 







nuclei were stained with DRAQ5 (Biostatus, DR50200) diluted 1:500 in PBS. Each 
matrix on cover glass was placed on microscope slides and covered by an 18-mm cover 
glass with a mounting medium of 50 (v/v) % glycerol in PBS. Cells were imaged with a 
20x objective on a Nikon Ti-E microscope, and fluorescence images were analyzed by 
Nikon NIS-Elements AR software (version 3.2). The percentage of cells that had 
incorporated BrdU was evaluated. Three to five replicates per group were examined and 
at least 120 cells per replicate were counted. 
Cell Spreading: 
 After 10 h of seeding, cells on cover glasses or protein matrices were rinsed with 
PBS, fixed with 4 (w/v) % formaldehyde in PBS for 30 min, and rinsed with PBS. Cells 
were permeabilized with 0.1 (v/v) % triton in PBS for 25 min and stained with a 
fluorescein isothiocyanate (FITC)-labeled phalloidin (Sigma, P5282) at 0.5 µg/mL in 
PBS for 40 min. Nuclei were stained for 15 min with DRAQ5 (Biostatus, DR50200) 
diluted 1:500 in PBS. Each matrix on cover glass was mounted on microscope slide and 
covered with an 18-mm cover glass with a mounting medium of 50 (v/v) % glycerol in 
PBS. Cells on matrices were imaged using a 20x objective on a Nikon Ti-EC-1 Plus 
microscope. Fluorescence images were analyzed by Nikon NIS-Elements AR software 
(version 3.2) to quantify cell area and circularity. Each group has four to six replicates 
and at least 60 cells were counted per replicate. 
Internalization of Acetylated-Low Density Lipoprotein (ac-LDL): 
 At each time point, cells were reseeded on an 8-well Lab-Tek Chamber Slide 
(Thermo Scientific, 154534) at a density of 10,000 cells/cm
2
 for 4 h. Then, cells were 
incubated for 4 h with acetylated-LDL conjugated with 1,1'-dioctadecyl-3,3,3',3'-
tetramethyl-indocarbocyanine perchlorate (Dil-ac-LDL) (Alfa Aesar, BT-902) at a 
concentration of 2 µg/mL. Cells were rinsed with PBS and fixed with 4% formaldehyde 
in PBS for 25 min. After washing wells with PBS three times, the chambers were 
removed, and the slide was stored in a mounting solution of 50% glycerol in PBS.  
The internalization of Dil-ac-LDL by cells was imaged by a TRITC filter cube on 







determined by threshold levels at which proliferating group had minimal fluorescence. 
Total number of cells per image was counted using phase contrast image, and the 
percentage of cells internalized Dil-ac-LDL was evaluated. Four replicates per group 
were examined. 
Statistical Analysis: 
Data are represented as mean ± standard deviation. First, Shapiro-Wilk and 
Levene‘s modified tests were used to confirm normality and homogeneity of variance, 
respectively. If data satisfied both assumptions, one-way analysis of variance (ANOVA) 
followed by Tukey‘s post hoc test were conducted to evaluate statistical differences 
between experimental groups. For data showing unequal variances, a Box-Cox 
transformation was conducted [80]. Because water content data (Figure 4B) did not show 
equal variance even after data transformation, Welch‘s test and Games-Howell test were 
performed to evaluate statistical differences between groups. All statistical analyses were 
performed by Statistical Analysis Software (SAS, version 9.2) except for water content 
data that was analyzed by Minitab (version 17). A statistical significance represents if a 
p-value was less than 0.05. 
4.4 Results 
Production of Proteins and Matrices: 
 The RZ-RGD and RZ-scRGD proteins were designed and produced as previously 
described [57]. The full amino acid sequences of the proteins are shown in Figure 4.4.1A. 
Briefly, in the RZ-RGD protein, a resilin-like sequence provides structural integrity and 
the RGD cell-binding sequence is included to promote cell adhesion. The RZ-scRGD 
protein serves as a negative control protein for cell adhesion as the order of glycine and 
aspartic acid residues in the RGD domain has been scrambled to disrupt the interaction 
between cells and the RGD sequence. The yield of the RZ-RGD and RZ-scRGD proteins 
were 57 and 90 mg per liter of culture, respectively. The purity of the proteins was 
confirmed by SDS-PAGE gels followed by densitometry analysis. The RZ-RGD and RZ-








Figure 4.4.1 Our proteins can form gels by crosslinking with transglutaminase (TGase). 
(A) The amino acid sequences of proteins used in this study are shown. In the RZ-RGD 
protein, the RGD cell-binding sequence is included on the C-terminus of resilin structural 
domain to promote cell adhesion. The RZ-scRGD protein serves as a sequence-scrambled 
negative control protein for cell adhesion. Bold letters represent glutamine and lysine 
residues that are used for TGase-mediated crosslinking. (B) The crosslinking reaction 
between the RZ proteins is shown. Top: In the presence of calcium ions, TGase can form 
covalent bonds between a primary amine of lysine residues and a γ-carboxamide group of 
glutamine residues. Red indicates the resilin domain and blue indicates the RGD or 
scrambled domain, respectively. Bottom: The uncrosslinked solution containing the 
proteins and TGase (left) becomes a white crosslinked gel (right) upon incubation at 37 
˚C. The protein and TGase concentration used in this figure were 6% and 2 U/mL, 
respectively. 
In this study, we chose transglutaminase to create crosslinked matrices, hereafter 
referred to as the RZ-TGase matrices. Transglutaminase forms ε-(γ-glutamyl) lysine 
amide bonds between a γ-carboxamide group of glutamine (Q) and a primary amine 
group of lysine (K) in the RZ proteins, as presented in Figure 4.4.1B. There are twenty 
two glutamines and seven lysine residues in each protein, and most of them (i.e., 87%) 







involved in TGase-mediated crosslinking because there are no glutamine or lysine 
residues in these domains. Upon crosslinking at 37 °C in the presence of calcium ions, a 
clear mixture containing the RZ proteins and enzyme became a white crosslinked gel 
(Figure 4.4.1B). 
Resilin-based proteins can be crosslinked with amine-reactive chemical 
crosslinkers, such as tris(hydroxymethyl)phosphino]propionic acid (THPP) [58] or 
tris(hydroxylmethyl)phosphine (THP) [54, 57]. Unlike these chemical crosslinkers, 
transglutaminase mediates crosslinking reactions and does not exist in a crosslinked 
network (Figure 4.4.1B). Our preliminary experiments found that cell attachment was 
different on crosslinked matrices, depending on crosslinking chemistry. The RZ-TGase 
matrices and chemically crosslinked RZ-THP matrices were produced at 6 and 12% and 
both crosslinking chemistries did not disrupt the RGD domain in the RZ-RGD protein. 
The surface contact angle and the number of cells at 10-16 h after seeding were similar 
on both matrices at each concentration (data not shown). However, at a later time point at 
day 6-7, fewer cells were observed on the RZ-THP matrices than the RZ-TGase matrices, 
especially at high protein concentration (Figure 4.4.2). This result suggests that cell 
attachment may be dependent on crosslinking chemistry, as we observed weaker cell 








Figure 4.4.2 hMSC attachment was different on crosslinked matrices, depending on 
crosslinking chemistry. Cell viability on enzymatically crosslinked RZ-TGase matrices or 
chemically crosslinked RZ-THP matrices was examined at 6-7 days by LIVE/DEAD 
assay. Images of LIVE/DEAD assay are shown. Live cells are green, and dead cells are 
red. At both concentrations, cell number was much lower on the RZ-THP matrices 
compared to the RZ-TGase matrices. Of particular, few cells were found on 12% RZ-
THP matrices. Dashed lines indicate the edge of the matrices. Scale bar represents 500 
µm. 
Mechanical Properties of the RZ-TGase Matrices: 
To create the RZ-TGase matrices with a range of stiffness, we varied the total 
protein concentration (Figure 4.4.3A). Because previous reports suggest that RGD 
density on matrices can also affect cell behavior [68, 151], we maintained constant RGD 
density for all matrices by mixing the RZ-RGD protein with the RZ-scRGD protein. The 
enzyme concentration was chosen at 2 U/mL, at which homogeneous matrices were 








Figure 4.4.3 Mechanical properties of the RZ-TGase matrices can be tuned by total 
protein concentration. (A) Summary of crosslinking conditions and measurement results 
are shown. (B) A strain sweep was conducted on the RZ-TGase matrices at 37 °C over a 
range of 0.1 to 10% to determine linear viscoelastic region. (C) A frequency sweep was 
performed at 37 °C with a range of 0.1 to 10 rad/s. All storage moduli were independent 
on the tested frequency range. (D) Average moduli of the matrices at all concentrations 
were statistically different from each other. Letters indicate statistically different Tukey 
groups. All data are represented as the average ± standard deviation of three replicates. 
We measured bulk mechanical properties of the RZ-TGase matrices on a 
rheometer at 37 °C. First, the linear viscoelastic region was determined by performing a 
strain sweep in a range from 0.1 to 10% strain at a frequency of 1 rad/s (Figure 4.4.3B). 







and was independent of strain at all concentrations. Thus, all subsequent experiments 
were performed at 1% strain which was within the linear viscoelastic region. A frequency 
sweep was performed in a range of 0.1 to 10 rad/s, and showed that the RZ-TGase 
matrices at all concentrations were stable over the tested frequency range (Figure 4.4.3C).  
Time sweeps of the RZ-TGase matrices were performed at 37 °C (Figure 4.8.2) 
and gelation time was determined as the time when the storage modulus exceeded the 
loss modulus (G‘‘). Average gelation time increased from 57 s for 6% matrices to 336 s 
for 12% matrices (Figure 4.4.3A), suggesting that gelation time depends on total protein 
concentration. The shear moduli of the matrices are presented in Figure 4.4.3A and D. 
The average G‘ varied from 44 Pa for 6% matrices to 7072 Pa for 12% matrices, and G‘ 
were one or two orders of magnitude higher than G‖ at all concentrations (Figure 4.8.2). 
Shear moduli at all concentration were statistically different from each other (p < 0.05, 
Tukey’s post hoc test) (Figure 4.4.3D). Thus, matrix stiffness was easily tuned by varying 
total protein concentration. 
Characterization of the RZ-TGase Matrices: 
Swelling ratio and water content of the RZ-TGase matrices were evaluated 
(Figure 4.4.4). The matrices were produced on cover glasses and soaked in PBS at 37 °C 
for 3 days. We observed that all matrices reached swelling equilibrium after 3 days of 
swelling as there was no significant change in swelling ratio of each matrix at that time 
(data not shown). After 3 days of swelling, swelling ratios of 6, 8, 10, and 12% matrices 
were 13.2, 10.5, 9.4, and 8.4, respectively, and they were statistically different from each 
other (p < 0.05, Tukey’s post hoc test). The percentage of water content of 6, 8, 10, and 
12% matrices was 92.4, 90.5, 89.4, and 88.0%, respectively, and the water content of 6% 
matrices was statistically different from that of 12% matrices (p < 0.05, Games-Howell 
test). Overall, we observed a decreasing trend in swelling ratio and water content as the 








Figure 4.4.4 Swelling ratio and water content of the RZ-TGase matrices. (A) Equilibrium 
swelling ratios of the matrices were measured after 3 days of incubation in PBS at 37 °C. 
The swelling ratio decreased as total protein concentration increased. (B) The percentage 
of water content of the matrices is shown. The percentage of water content of 6% 
matrices was statistically higher than that of 12% matrices. Letters indicate statistically 
different (A) Tukey groups or (B) statistically different groups determined by Games-
Howell test. Data are represented as the average ± standard deviation of four to five 
replicates. 
Cell Viability and Proliferation on the RZ-TGase Matrices: 
 First, hMSC viability on the matrices was determined by LIVE/DEAD assay. As 
shown in Figure 4.4.5, cell viability on the RZ-TGase matrices or glass surface was at 
least 94.0% at day 2, and there was no statistical difference in cell viability between 
groups (p > 0.05, one-way ANOVA). At a later time point at day 7, cells on matrices 
remained highly viable (Figure 4.8.3). This result suggests that the RZ-TGase matrices 
are cytocompatible. Next, cellular metabolic activity on the matrices was measured by 
WST-1 assay (Figure 4.4.6A). After 1 day of seeding, hMSCs on the matrices exhibited 
statistically equivalent metabolic activity. Cellular metabolic activity on the matrices was 
statistically lower than that on glass surface, because metabolic activity is related to cell 
number and lower cell number was observed on the matrices than glass surface (Figure 
4.4.5A). Finally, cell proliferation on the matrices was evaluated by BrdU cell 
proliferation assay (Figure 4.4.6B-C), which measures BrdU incorporation by actively 
proliferating cells. After 2 days, cells on all surfaces were incubated with BrdU for 24 h. 







that on glass surface was 71%. Overall, cell viability and proliferation were equivalent on 
all RZ-TGase matrices.  
 
Figure 4.4.5 hMSCs were viable on the RZ-TGase matrices. (A) Cells were grown on 
glass surface or on matrices for 2 days, and cell viability was evaluated by LIVE/DEAD 
assay. Images of LIVE/DEAD assay are shown. Live cells are green, and dead cells are 
red. Dashed lines indicate the edge of the matrices. Scale bar represents 500 µm. (B) Cell 
viability at day 2 was quantified. Cells showed at least 94.0% viability on all surfaces, 
and there was no significant difference in cell viability between groups as confirmed by 
one-way ANOVA (p > 0.05). Data are represented as the average ± standard deviation of 








Figure 4.4.6 hMSC proliferation on the RZ-TGase matrices was measured. (A) Metabolic 
activity of cells on the matrices was assessed by the WST-1 assay at day 1, and the results 
are shown relative to metabolic activity of cells on glass surface. Cellular metabolic 
activity on all RZ-TGase matrices was statistically equivalent each other, and 
significantly lower compared to that on glass surface. This difference in metabolic 
activity between the matrices and glass surface could be due to lower cell number on the 
matrices compared to glass surface. (B) BrdU cell proliferation assay was performed to 
evaluate BrdU incorporation by actively proliferating cells. After 2 days, cells on glass or 
on the matrices were incubated with BrdU for 24 h, and BrdU incorporation was 
quantified by evaluating the percentage of BrdU-incorporated cells. The percentage of 
BrdU-positive cells on the matrices was 50-57%, while that on glass surface was 71%. (C) 
Images of the BrdU assay are shown. Green and red indicate incorporated BrdU and 
nuclei, respectively. Scale bar represents 100 µm. Letters indicate statistically different 
Tukey groups. Data are represented as the average ± standard deviation of three to five 
replicates. 
Cell Spreading Depends on Matrix Stiffness: 
 Cell spreading on the RZ-TGase matrices was examined at 10 h after seeding by 
fluorescently staining actin stress fibers. Because the solution of the RZ-RGD and RZ-
scRGD proteins was pre-mixed and then underwent crosslinking, we assumed that RGD 







spreading. Figure 4.4.7A shows hMSC morphology on matrices varying stiffness. Cells 
on the softest matrices (i.e., 6%) showed a round morphology, whereas cells on the 
stiffest matrices (i.e., 12%) exhibited extensive spreading. Cells on the matrices with an 
intermediate stiffness (i.e., 8 and 10%) showed an intermediate spreading behavior 
between those on the softest and stiffest matrices. Quantitative analysis of cell spreading 
was performed by evaluating cell area and circularity (Figure 4.4.7B). On the softest 
matrices, cells exhibited the smallest cell area and the greatest circularity. In contrast, 
cells on the stiffest matrices showed the largest cell area and the smallest circularity. Of 
particular, these two variables for cell spreading were statistically equivalent on the 
stiffest matrices and glass surface. Overall, our results suggest that the stiffness of the 








Figure 4.4.7 hMSC spreading on the matrices was dependent on matrix stiffness. (A) 
Actin stress fibers of cells on the matrices were stained after 10 h of seeding. Green and 
red represent actin fibers and nuclei, respectively. Scale bar represents 100 µm. (B) Cell 
spreading was quantified by evaluating cell area and circularity. Cells on 6% matrices 
exhibited the smallest cell area and greatest circularity, whereas cells on 12% matrices 
showed the greatest cell area and smallest circularity. Letters indicate statistically 
different Tukey groups. Data are represented as the average ± standard deviation of four 
to six replicates. 
Matrix Stiffness Modulates Endothelial Differentiation of hMSCs: 
 Endothelial differentiation of hMSCs on the RZ-TGase matrices was evaluated by 
functional behavior of endothelially differentiated cells. The internalization of ac-LDL is 
a characteristic behavior of endothelial cells [152], and previous studies showed that 
endothelially differentiated cells showed a similar behavior to mature endothelial cells 
[118, 119]. After 14 days of differentiation, ac-LDL internalization by cells on matrices 
was examined by ac-LDL uptake assay (Figure 4.4.8). Cells on glass surface served as 
our positive control for endothelial differentiation, because previous reports demonstrated 
that MSCs can be differentiated into endothelial lineage on hard surfaces in the presence 








Figure 4.4.8 Endothelial differentiation of hMSCs was modulated by matrix stiffness. 
The internalization of acetylated low density lipoprotein (ac-LDL) by cells on the RZ-
TGase matrices was evaluated after 14 days of differentiation by ac-LDL uptake assay. 
The percentage of cells that had internalized ac-LDL was quantified. The result shows 
that ac-LDL internalization by cells on all matrices at day 14 was statistically higher 
compared to that of proliferating cells at day 0 (prolif) and statistically equivalent to that 
on glass surface at day 14. At day 14, the uptake of ac-LDL by cells on 12% matrices was 
higher compared to that on 6% matrices. Letters indicate statistically different Tukey 
groups. Data are represented as the average ± standard deviation of four replicates. 
At day 0, only 1.32% of proliferating cells internalized ac-LDL. In contrast, at 
day 14, all groups showed increased ac-LDL internalization, compared to proliferating 
group. The percentage of cells positive for ac-LDL was 38.7 ± 27.7% on 6% matrices and 
77.7 ± 6.7% on 12% matrices, both of which were statistically different from each other 
(p < 0.05, Tukey’s post hoc test). This observation suggests that the 7072 Pa stiffness of 
12% matrices promoted higher endothelial differentiation compared to the 44 Pa stiffness 
of 6% matrices. In addition, cells on all matrices at day 14 showed statistically equivalent 
ac-LDL internalization to cells on glass surface at day 14. 
4.5 Discussion 
Cells are exposed to many environmental cues that affect cell response. Among 
the cues, microenvironment stiffness and its effect on cell response have been widely 
recognized and studied. Upon adhesion on a matrix (or substrate), a cell generates 







depending on its stiffness and in turn the cell responds to this resistance force. This cell-
matrix interaction is associated with adhesion molecules (e.g., integrins) and cellular 
cytoskeleton and regulates cell behavior on the matrix.  
Matrices have been produced with different chemistries and their stiffness was 
tuned by changing chemical crosslinker concentration [141], enzyme concentration [154], 
and crosslinking time (i.e., photopolymerization time) [147, 155]. In our study, we have 
utilized enzyme-mediated crosslinking to create protein matrices and varied matrix 
stiffness by changing protein concentration at a fixed enzyme concentration. 
Transglutaminase is an enzyme found in a variety of tissues, such as brain and skin, and 
plays a role in stabilization and remodeling of extracellular matrix and wound healing 
process [42]. Because of its natural origin and mild crosslinking conditions, tissue-
derived transglutaminase has been employed to create matrices and hydrogels [148, 156], 
and to functionalize materials with biomolecules [157, 158].  
The RZ-RGD and RZ-scRGD proteins used in this study contain glutamine and 
lysine residues that participate in transglutaminase-mediated crosslinking (Figure 4.4.1). 
We have tuned matrix stiffness over two orders of magnitude. Our RZ-TGase matrices 
can be categorized into three groups by their stiffness: softest, intermediate, and stiffest 
matrices. As shown in Figure 4.4.3A and D, the softest, intermediate, and stiffest 
matrices had a 44, 91-402, and 7072 Pa of modulus, respectively. The fast gelation time 
(Figure 4.8.2) and frequency- and strain-independent behaviors of all our matrices 
(Figure 4.4.3B-C) were similar to those of other resilin-based protein gels that had been 
chemically crosslinked [57, 58, 159]. We have characterized swelling ratio and water 
content of the matrices (Figure 4.4.4). Because higher protein concentration resulted in 
denser crosslinked network, matrices produced at high protein concentration showed 
lower swelling ratio and water content compared to those at low concentration.  
Our results suggest that the degree of matrix stiffness did not affect viability and 
proliferation of cells on the matrices (Figure 4.4.5 and Figure 4.4.6). However, compared 
to cells on glass surface, cells on our matrices showed reduced proliferation (Figure 
4.4.6), which has been observed by cells on soft matrices with stiffness of 1 kPa [160]. 







demonstrated [155, 161, 162]. We observed that cells developed a broader morphology 
on the stiffest matrices at 7072 Pa, whereas cells exhibited small and rounded 
morphology on the softest matrices at 44 Pa (Figure 4.4.7). Of particular, cells on the 
stiffest matrices exhibited statistically equivalent spreading behavior to those on hard 
glass surface. Cell circularity, which implies cell polarization (i.e., indicator of 
asymmetrical cell shape), was the highest and lowest on the softest and stiffest matrices, 
respectively (Figure 4.4.7B). Previous report suggests that cell polarization is dependent 
upon matrix stiffness and controlled by focal adhesion [163]. 
Given the fact that endothelial cells present on soft, native environments with a 
modulus of 3000 Pa [144], tissue culture plastic or glass that were routinely used for in 
vitro experiments cannot mimic sub-endothelial environments. Previous studies reported 
matrix stiffness suitable for endothelial function and endothelial differentiation. For 
example, endothelial cells exhibit network formation on soft matrices such as Matrigel 
that has a shear modulus of 100 Pa [164]. This network formation by endothelial cells 
failed when the matrix modulus was above 2500 Pa [146]. Similarly, one study showed 
that endothelial differentiation of stem cells was influenced by matrix stiffness. It 
demonstrated that the matrix with a shear modulus of 150 Pa (or compressive modulus of 
2 kPa) increased endothelial marker expression of rat MSCs compared to the matrix with 
the modulus of 250 Pa (or compressive modulus of 17 kPa) [147].  
We showed that endothelial differentiation of hMSCs was achieved even on softer 
environments than glass surface, as internalization of ac-LDL by cells on our matrices 
was statistically equivalent to that on glass surface (Figure 4.4.8). This observation 
implies that the use of our matrices may be beneficial for endothelial cell differentiation, 
because our matrices have stiffness close to that of subendothelium and thus more closely 
mimic native endothelial cell environments compared to glass surface. In addition, cell 
differentiation was modulated by matrix stiffness; the internalization of ac-LDL by cells 
was statistically higher on the stiffest matrices at 7072 Pa, compared to the softest 
matrices at 44 Pa. Overall, our result indicates that matrix stiffness can serve as 








In our study, we created protein matrices by crosslinking with transglutaminase, 
and tuned matrix stiffness between 44 to 7072 Pa by varying total protein concentration. 
The matrices were characterized by evaluating swelling ratio and water content and both 
variables decreased as the degree of crosslinking increased. We showed that hMSCs were 
viable and proliferated on the matrices. In addition, matrix stiffness modulated spreading 
and endothelial differentiation of hMSCs, as we observed that the stiffest matrices 
increased cell spreading and differentiation compared to the softest matrices. Finally, 
endothelial differentiation on our matrices was statistically equivalent to that on glass 
surface. Thus, our tunable matrix system is a promising tool to obtain endothelial-like 
cells and to provide more native sub-endothelial environments compared to conventional 
culture substrate. 
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4.8 Supporting Information 
 
Figure 4.8.1 The purity of the RZ-RGD and RZ-scRGD proteins used in this study was 
assessed by SDS-PAGE analysis. Both proteins appeared near the expected molecular 
weight of 18.6 kDa. The purity was confirmed by densitometry analysis, which was 96% 








Figure 4.8.2 Time sweeps of the RZ-TGase matrices were conducted at 37 ˚C with 
angular frequency at 1 rad/s and 1% strain for 1 h. The total protein concentration of the 
matrices was at (A) 6, (B) 8, (C) 10, or (D) 12%. Crosslinking occurred within 6 min 






































































































































Figure 4.8.3 hMSCs were viable at 7 days. Cell viability was evaluated by LIVE/DEAD 
assay, and images of LIVE/DEAD are shown. Live cells are green, and dead cells are red. 
Images of 6 and 12% matrices are from the same experiment as shown in Figure 4.4.2. 









CHAPTER 5. CONCLUSIONS  
5.1 Summary 
This work demonstrated that protein-engineered microenvironments can be 
promising tools for tissue engineering applications. The microenvironments were created 
by surfaces or matrices of proteins that contain a resilin-like sequence. Our 
microenvironments were cytocompatible and supported proliferation of human 
mesenchymal stem cells (hMSCs). Differentiation of hMSCs was modulated by 
biochemical or biophysical cues in the protein-based microenvironments. 
First, a peptide derived from bone morphogenetic protein-2 (i.e., BMP-2 peptide) 
was incorporated into our modular proteins. Within the context of our proteins, the BMP-
2 peptide was active and accelerated osteogenic differentiation of human mesenchymal 
stem cells (hMSCs) as it increased alkaline phosphatase activity, calcium deposition, and 
expression of bone-related genes. Interestingly, the BMP-2 peptide did not synergize with 
the RGD cell-binding sequence within the context of our modular proteins.   
Second, cell differentiation toward different lineages was achieved by switching 
biochemical cues in our microenvironments. We replaced the BMP-2 peptide with a 
peptide derived from vascular endothelial growth factor (i.e., QK peptide) in our proteins. 
The surface of our proteins containing the QK peptide promoted endothelial 
differentiation of hMSCs in the absence of exogenous growth factors as they increased 
endothelial gene and protein expression and endothelial functions compared to negative 
control surfaces (i.e., tissue culture plastic). Of particular note, hMSCs on proteins 









Finally, biophysical cues in our protein-based microenvironments influenced cell 
response, including endothelial differentiation. The proteins contain the RGD cell-
binding sequence to promote cell adhesion. Protein matrices were created with tissue 
transglutaminase, and the matrix stiffness was tuned by varying total protein 
concentration. The matrix stiffness modulated spreading and differentiation of hMSCs as 
the stiffest matrices promoted greater cell spreading and higher endothelial differentiation 
compared to the softest matrices. 
5.2 Future Directions 
This work demonstrated that the BMP-2 peptide in modular RZ-BMP proteins 
accelerated osteogenic differentiation of hMSCs. In addition, we showed that the BMP-2 
peptide did not synergize with the RGD cell-binding sequence within the context of our 
modular proteins. The work of Moore et al. demonstrated that the surface concentration 
and mode of presentation (i.e., single or combinatorial) of both peptides grafted on 
surfaces affected osteogenic differentiation [27]. Thus, future work will investigate the 
combination and surface density of BMP-2 and RGD within the context of proteins that 
influence osteogenic differentiation of hMSCs. 
There have been studies showing the effect of matrix stiffness on osteogenic 
differentiation. Engler et al. demonstrated that matrix stiffness of 25-40 kPa induced 
osteogenic differentiation of hMSCs [34]. Zouani et al. showed that the BMP-2 peptide 
presented on matrices had different effects on osteogenic differentiation depending on 
matrix stiffness. When the BMP-2 peptide was immobilized on a matrix with stiffness of 
0.5-3.5 kPa, it had no effect on differentiation whereas the peptide immobilized on a 
matrix with stiffness of 45-49 kPa increased differentiation [39]. Therefore, future studies 
will examine the interplay of matrix stiffness and the BMP-2 peptide incorporated in 
crosslinked RZ-BMP matrices on osteogenic differentiation. 
This work also showed that our RZ-QK proteins promoted endothelial 
differentiation of hMSCs. Previous reports demonstrated that full-length BMP-2 and 
VEGF had a synergistic effect on bone formation and angiogenesis (i.e., formation of 







formation in vivo through enhancing angiogenesis. Furthermore, the ratio of VEGF and 
BMP-2 affected the degree of bone formation [165]. Another study showed that the 
combination of BMP-2 and VEGF enhanced endothelial cell migration and network 
formation compared to either BMP-2 or VEGF alone [166]. Thus, future studies will 
examine the combinatorial effect of the BMP-2 peptide and the QK peptide on osteogenic 
or endothelial differentiation of hMSCs. 
Finally, this work demonstrated that endothelial differentiation was achieved on 
soft matrices compared to conventional hard surfaces, and the matrix stiffness modulated 
endothelial differentiation of hMSCs. Given the fact that endothelial cells reside on the 
inner surface of blood vessels, Lee et al. produced tubular vasculature containing an 
endothelial cell layer by rolling nanofibrous substrates [167]. Future studies will 
investigate the construction of a three-dimensional (3D) vascular structure by using 
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Appendix A Molecular Cloning 
DNA sequences encoding proteins used in Chapters 2 (i.e., RZ-BMP and RZ-scBMP) 
and 3 (i.e., RZ-QK and RZ-scQK) are shown. The BMP-2 and QK peptide sequences are 
derived from full-length BMP-2 and VEGF, respectively. Sequence-scrambled proteins 
such as RZ-scBMP and RZ-scQK served as negative control proteins.  
DNA oligonucleotides for bioactive domains (BA) were purchased from Sigma in the 
50 nanomolar scale. All cloning was modeled with Geneious Pro software and performed  
using the scheme shown in Figure A.1. Full DNA sequences of pET28aRW-RZ10-BA 
(only single stranded DNA) and the corresponding amino acid sequences with important 
restriction sites are shown in Figure A.2, Figure A.3, Figure A.4, and Figure A.5. The 
amino acid sequences of resilin and bioactive domains are shown in red and blue, 
respectively. 
 

















Figure A.2 DNA sequence of pET28aRW-RZ10-QK vector encoding amino acids of RZ-
QK 
DNA sequences encoding RZ-scQK, RZ-BMP, and RZ-scBMP proteins in 
pET28aRW-RZ10-sQK, pET28aRW-RZ10-BMP, and pET28aRW-RZ10-sBMP vectors 
are exactly the same as that of pET28aRW-RZ10-QK vector except for the amino acid 
sequence in the bioactive domain between the XhoI and BsmI restriction sites. 
 
Figure A.3 DNA sequence of pET28aRW-RZ10-sQK vector encoding amino acids in 
bioactive domain of the RZ-scQK protein. 
 
Figure A.4  DNA sequence of pET28aRW-RZ10-BMP vector encoding amino acids in 









Figure A.5  DNA sequence of pET28aRW-RZ10-sBMP vector encoding amino acids in 








Appendix B Protein Expression and Purification 
 
Figure B.1 Purification conditions of resilin-based proteins were screened by (A) testing 
different amounts of ammonium sulfate in the salting-out step and (B) testing different 
orders of the heating and dialysis steps. (A) The protein containing thirty repeats of the 
resilin sequence and the RGD sequence (RZ30-RGD) was purified by adding 5, 10, 15, 
20, 25, or 30% ammonium sulfate to the lysed cell solution. The results suggest that 20% 
ammonium sulfate is necessary to precipitate out the desired protein from the lysed cell 
solution. P: pellets resuspended in water at 50 mg/mL, S: supernatant from salting-out 
step. The red arrow indicates the expected molecular weight of RZ30-RGD at 48.8 kDa. 
(B) The protein containing ten repeats of the resilin sequence and the VEGF-mimicking 
peptide (RZ-QK) was purified by changing the order of the heating and dialysis steps. 
The results show that the order of the heating and dialysis steps did not affect protein 
purity. Lanes 1 and 2: 20% samples that were dialyzed before heating. Lanes 3-5: 
samples that were heated first without pre-dialysis. DHP: dialyzed and heated, heat 
pellets, DHS: dialyzed and heated, heat supernatant, HS: heat supernatant, HSD: heat 








Appendix C Endothelial Differentiation and Condition 
To prevent lot-to-lot variability of serum, fetal bovine serum (FBS) was screened for 
endothelial differentiation of human mesenchymal stem cells (hMSCs). Two types of 
FBS from Atlanta Biologics (hereafter referred to as Atlanta) and Thermo Scientific 
(referred to as Thermo) were purchased and tested with endothelial differentiation assays. 
Cells at P4 were cultured in endothelial basal medium (EBM) or endothelial growth 
medium (EGM). Both EBM and EGM contained 2% serum from either Atlanta or 
Thermo whereas maintenance medium (MM) contained 10% serum from Lonza. 
As a result, endothelial differentiation of human MSCs was improved with FBS 
from Atlanta Biologics (Cat number S11595, Lot number E12070) as cells in EGM 
exhibited increased ac-LDL internalization and network formation compared to those in 
EBM (Figure C.1). Therefore, the FBS from Atlanta Biologics was chosen for all 










Figure C.1 Cell proliferation and differentiation in different sera were examined. (A) 
Metabolic activity of human MSCs differentiated in endothelial media containing 
different sera was measured at day 13 of differentiation by WST-1 assay. Metabolic 
activity of cells grown in EGM was higher than that in EBM due to the presence of 
growth factors in EGM. There was no statistical difference in metabolic activity of cells 
grown in the two types of EGM. Letters indicate statistically different Tukey groups. (B) 
The internalization of ac-LDL by cells was evaluated after 7 days of differentiation by ac-
LDL uptake assay. With Atlanta FBS, there was a significant difference in ac-LDL 
internalization between cells grown in EBM and EGM. Scale bar represents 50 µm. (C) 
Network formation was examined after 15 days of differentiation by an in vitro 
angiogenesis assay. More significant network formation was observed by cells 
differentiated in EGM containing Atlanta FBS. The images were taken after 7 h 








Using the serum from Atlanta Biologics, endothelial differentiation conditions 
were furthered tested by flow cytometry as shown in Figure C.2. At 2 weeks of 
differentiation, cells grown in EGM containing additional VEGF at 50 ng/mL enhanced 
CD34 and CD144 markers and increased internalization of ac-LDL compared to cells 
grown in EBM.  
 
Figure C.2 Endothelial differentiation of human MSCs was evaluated by flow cytometry. 
Cells were differentiated for 14 days in EBM or EGM supplemented with additional 
VEGF at 50 ng/mL (EGM+VEGF). The EGM+VEGF medium is the same as the positive 
differentiation medium (PDM) used in Chapters 3 and 4 and contained a total VEGF 
concentration at 52 ng/mL. At 14 days of differentiation in the EGM+VEGF medium, a 
few cells started to express CD 34 and CD 144 markers, and 45.8% cells internalized ac-
LDL. Numbers at the top and bottom right of each figure indicate cells exhibiting 









In addition, we investigated whether adding VEGF at 50 ng/mL to EGM 
enhanced endothelial differentiation. First, cells grown in EGM containing additional 
VEGF at 50 ng/mL had increased ac-LDL internalization at day 12 compared to 
proliferating cells at day 0 and cells grown in EBM at day 12 (Figure C.3). However, the 
presence of VEGF at 50 ng/mL in EGM did not improve ac-LDL internalization as there 
was no significant difference in ac-LDL internalization by cells grown in EGM-VEGF 
and EGM+VEGF media (Figure C.4). EGM-VEGF media contained VEGF from the kit 
at 2 ng/mL, whereas EGM+VEGF media contained the total VEGF concentration at 52 
ng/mL. 
 
Figure C.3 Endothelial differentiation conditions of human MSCs was screened by 
culturing cells in different types of media. Cells were grown in EBM or EGM+VEGF 
media, and cell differentiation was evaluated by ac-LDL internalization at day 0 
(proliferating) and 12. The total VEGF concentration in EGM+VEGF medium was 52 
ng/mL. At day 12, the EGM+VEGF group exhibited higher ac-LDL internalization than 









Figure C.4 Endothelial differentiation conditions of human MSCs was screened by 
culturing cells in different types of medium and evaluating ac-LDL internalization. Cells 
were grown in EGM without VEGF (EGM-VEGF) or EGM+VEGF. At day 12, there was 
no statistical difference in ac-LDL internalization between cells grown in EGM-VEGF 








Appendix D Resilin-based Protein Films 
 
Figure D.1 Chemically-crosslinked resilin-based protein  films were confirmed by 
colorimetric Western blot. The RZ-scQK protein containing ten repeats of resilin was 
adsorbed on coverglasses overnight and crosslinked with tris (hydroxymethyl)phosphine 
(THP) at 37 ˚C. The molar crosslinking ratio of hydroxymethylphosphine (HMP) in THP 
to primary amine in RZ-scQK was 50:1. The minimum crosslinking time was screened, 
and film stability was confirmed by incubating the film in 0.05% SDS for 24 h at room 
temperature before Western blot. The purple color indicates the presence of a THP-
crosslinked resilin protein film on the coverglass. The films that had crosslinked for at 
least 30 min was stable in SDS, indicating that 30 min may be necessary for complete 









Figure D.2 Conjugation of resilin-based proteins with sulfo-SANPAH (SS) before 
production of photocrosslinked resilin films was confirmed by the trinitrobenzene 
sulfonic acid (TNBSA) assay. The RZ-RGD protein containing ten repeats of resilin was 
conjugated with SS for 4 h. The percentage of conjugated lysines in RZ-RGD with SS 
increased as the molar ratio of SS to amine groups in RZ-RGD increased. Numbers in 
each bar represent the percentage of lysines conjugated to SS. Letters indicate statistically 
different Tukey groups.  
 
Figure D.3 Photocrosslinking of resilin-based proteins conjugated with SS was confirmed 
by fourier transform infrared (FT-IR) spectroscopy. The RZ-RGD protein was conjugated 
with SS at a molar ratio of 2:1 (i.e., SS: amine). The solution of RZ-RGD conjugated 
with SS was placed in silicone molds on a microscopy slide and dried overnight at 50-60 
˚C. The dried protein (RZ-SS) film was exposed to UV light for 3 h. The azido 
characteristic peak at 2130 cm
-1
 was reduced in +UV film compared to –UV film, 








Appendix E Additional Protocols 
Flow Cytometry: Staining for endothelial cell markers on MSCs and HUVECs  
0. Prepare filtered 1x PBS containing 0.5% BSA (5 mg/mL)  
1. Reserve the machine before you do experiment 
2. Detach cells from plates, count cell number, and distribute 100,000 cells per sterile 1.7 
mL Eppendorf tube 
3. Pellet 1 x105 cells at room temperature at 500 g for 5 min for each staining condition. 
4. Remove the supernatant by pipettes and resuspend in 100 µL of 1x PBS containing 0.5% 
BSA  
From this point on, procedure is in dark 
5. Save one tube as unstained cells. If you have cells that have grown in multiple 
conditions, you should have unstained cells for individual group 
6. Add the appropriate amount of antibody to each tube, mix by pipetting and a quick 
pulse vortex, and incubate on ice for 20 min 
a. For proper selection of antibody, contact Dr. Jeffrey Woodliff 
(jwoodlif@purdue.edu) in Bindley. 
b. Each antibody vial comes with a recommended amount to use, but the antibody 
concentration can be screened. In this case, design your experiment first with Dr. 
Woodliff. 
c. For HUVECs and endothelial-like cells (screened by Yeji Kim on November 
2013) 
Marker name-fluorochrome/volume to use (screened)/recommended volume  
CD31-FITC (PECAM)/1.25 µL/5 µL (Biolegend, 303104) 
CD34-PE/5 or 10 µL/5 µL (Biolegend,343506) 
CD144-PE (VE-cadherin)/10 µL/20 µL (Biolegend,348506) 
CD309-Ax647 (VEGFR-2)/5 µL/5 µL (Biolegend,338909) 
LDL/2 µg/mL/10 µg/mL (Biomedical Technologies) 








8. Spin the cells down, remove the supernatant and resuspend in 0.5 mL PBS/BSA (for 5 
mL tubes) 
9. Bring stained cells on ice in DARK to Bindley 
10. Run FC500 
11. For training, contact Jill Hutchcroft (Hutchcroft@purdue.edu) 
FC500 in Bindley Bioscience Center Room 233 (Program: MXP cytometer) 
1. Place 5 mL tube containing 500 µL of unstained cells on the rack. The rack should be 
placed properly in the holder (THIS IS THE MOST IMPORTANT THING!) 
2. For setting with unstained cells, go to cytometer control. 
a. Open your protocol (example: Yeji Kim) 
b. Go to cytometer control 
i. If you need red laser, click laser enabled under ―Red laser shutter‖ 
ii. They have two lasers: Argon ion laser (488 nm) and Red solid state HeNe 
laser (631 nm) 
iii. Click Quickset (The bars will show up. These adjust voltage in PMT) 
iv. Click Setupmode (this is for setting. Once you find the best setting for my 
samples, you should UNCLICK Setpupmode before you run your actual 
samples 
v. Press close  
c. Go to Plate Wizard 
i. Clear plate 
ii. Click a well containing unstained cells 
iii. Select your protocol (Yeji Kim) and draw it to the plate 
iv. Check whether plate (rack) type is ―40 tube‖ 
v. For setting, volume: 50 µL and max event: 5000 
vi. Press OK. 
d. Press Run  









ii. Abort the plate to finish setting. 
3. Now, you are ready to run your samples. 
a. Go to Cytometer control 
i. Unclick Setupmode 
ii. Set Max to 10,000 events for 100,000 cells per sample  
iii. Set duration time to 300 s 
b. Place your samples on the rack (plate). Unstained cells should be run first. 
c. Go to Plate Wizard 
i. Assign samples with my protocol (Yeji Kim) 
ii. Change volume to 250 µL 
d. Press Run button. 
e. While they are running, keep monitoring program to check whether event number 
is increasing. If there are some clots or you don‘t have cells, the event number 
won‘t be increasing. 
Production of THP-crosslinked resilin-based protein film 
1. Adsorb RZ proteins at 1 mg/mL in PBS on acid-cleaned cover glasses overnight at 4 
˚C 
2. Next day, wash surfaces with PBS three times 
3. Place protein-side down on 70 µL THP solution 
4. Crosslink adsorbed protein surface with THP at 37 ˚C for 30 min  
a. Minimum molar ratio of HMP to amine was screened and determined to be 
50:1 
b. Minimum incubation time was screened and determined to be 30 min 
5. Place coverglasses into new plate and wash with PBS three times 
6. To check crosslinking, perform colorimetric Western blot analysis 
a. To check the stability of the film, incubate the film in 0.05% SDS for 24 h 








Conjugation of resilin-based proteins with sulfo-SANPAH 
1x buffer: For SS conjugation, the buffer does not necessarily have both HEPES and salts.  
The SS solubility decreases as salt concentration increases. 
(Note: Pierce said it does not necessarily have salts in the buffer and pH is the most 
important) 
1) Dissolve 8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4 in 900 mL MilliQ 
2) Adjust pH to 7.4 with NaOH 
3) Fill to final volume of 1L 
 
Sulfo-SANPAH (N-Sulfossuccinimidyl-6-(4‘-azido-2‘-nitrophenylamino) hexanoate, 
Pierce Biotechnology, Rockford, IL, 490.40 Da):  
1. Always work in dark 
2. Dissolve Sulfo-SANPAH (SS) and protein in 1x Buffer  
a. SS is moisture-sensitive. Equilibrate the vial to room temperature before 
opening. 
b. If SS is not dissolved well, warm up the solution in water bath at 37 °C. But, do 
not leave in buffer too long, otherwise SS will be hydrolyzed. 
c. pH of the solution is more important than temperature or salt concentration.  
d. Half-life time of NHS-ester 
i. 4-5 hrs at 0 °C, pH 7 
ii. 1 hrs at 0 °C, pH 8 
iii. 10 min at 4 °C, pH 8.6 
e. Do not mix SS solution by vortexing. Once they are stuck on the wall, they 
don‘t go back into solution well. 
3. Add protein solution to SS solution 
4. React protein with SS at room temperature for 30 min with stirring (~350 rpm) 
a. At 4 °C, react for 2 h 
b. If SS is conjugated to proteins, it turns red to orange color. 
5. Place reaction mixture onto microscopy slide with silicone mold in the DARK 








7. Before photo-crosslinking, pre-heat 21.7 mW/cm2 of 365 nm light (Blak-Ray  B-
100AP/R, Ultra Violet Products, Upland, CA) for 5-10 min 
8. Expose to UV lamp for 2 h 
a. Upon UV exposure, SS turns to rust brown. 
Measurement of conjugation of resilin-based protein with sulfo-SANPAH: TNBSA 
assay (modified from Pierce protocol) 
Reaction buffer (0.1 M sodium bicarbonate, pH 8.5): Dissolve 0.42 g sodium bicarbonate 
in 50 mL water  
1X buffer: 15 mM NaCl, 25 mM Na2HPO4 (pH 7.4) 
Note: make a standard solution every time you do the assay. 
          TNBSA is toxic. Work in the hood. 
1. Dissolve RZ proteins into the reaction buffer (RB) or 1X buffer directly 
a. Standard concentration: 0-2000 µg/mL (The minimum: ~ 25 µg/mL) 
b. Check pH of the buffer before use 
c. There is no difference in the slope of standard between reaction buffer and 1X 
buffer 
2. Make a 0.1 (w/v) % working TNBSA solution 
a. Dilute 5% TNBSA (stock in -20 °C) by 50 in the reaction buffer and mix well 
b. Work in the hood 
3. Add 0.25 mL of 0.1% (w/v) TNBSA working solution into the 0.5 mL of RZ-SS 
solution (or standard) and mix well. 
a. Since SS has background absorbance at 355 nm, react only SS solution (no 
conjugation with RZ) at the same concentration of SS in RZ-SS with TNBSA 
working (serve as blank for RZ-SS) 
4. Incubate them at 37 °C for 2 h with gentle shaking (~110 rpm) 
5. To each sample, add 0.25 mL 10% SDS to prevent protein precipitation and 0.125 
mL of 1N HCl to stop the reaction. 








b. Do not use higher concentration HCl (e.g. 6M) because SS in SS-RZ solution is 
precipitated. 
c. If you don‘t want to stop the reaction, measure the absorbance at 420 nm. 
6. Measure the absorbance at 355 nm of each sample (150 µL per well of a 96-well UV 
plate). If the absorbance is over 0.8, dilute the samples by 8 with ‗reaction 
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